id	sid	tid	token	lemma	pos
aiua-1760	1	1	65archivio	65archivio	NUM
aiua-1760	1	2	italiano	italiano	PROPN
aiua-1760	1	3	di	di	PROPN
aiua-1760	1	4	urologia	urologia	PROPN
aiua-1760	1	5	e	e	PROPN
aiua-1760	1	6	andrologia	andrologia	NOUN
aiua-1760	1	7	2013	2013	NUM
aiua-1760	1	8	;	;	PUNCT
aiua-1760	1	9	85	85	NUM
aiua-1760	1	10	,	,	PUNCT
aiua-1760	1	11	2	2	NUM
aiua-1760	1	12	introduction	introduction	NOUN
aiua-1760	1	13	the	the	DET
aiua-1760	1	14	low	low	ADJ
aiua-1760	1	15	specificity	specificity	NOUN
aiua-1760	1	16	of	of	ADP
aiua-1760	1	17	psa	psa	NOUN
aiua-1760	1	18	test	test	NOUN
aiua-1760	1	19	in	in	ADP
aiua-1760	1	20	diagnosing	diagnose	VERB
aiua-1760	1	21	prostate	prostate	NOUN
aiua-1760	1	22	cancer	cancer	NOUN
aiua-1760	1	23	(	(	PUNCT
aiua-1760	1	24	pca	pca	PROPN
aiua-1760	1	25	)	)	PUNCT
aiua-1760	1	26	,	,	PUNCT
aiua-1760	1	27	especially	especially	ADV
aiua-1760	1	28	for	for	ADP
aiua-1760	1	29	serum	serum	NOUN
aiua-1760	1	30	psa	psa	NOUN
aiua-1760	1	31	values	value	NOUN
aiua-1760	1	32	<	<	X
aiua-1760	1	33	10	10	NUM
aiua-1760	1	34	ng	ng	NOUN
aiua-1760	1	35	/	/	SYM
aiua-1760	1	36	ml	ml	PROPN
aiua-1760	1	37	is	be	AUX
aiua-1760	1	38	due	due	ADJ
aiua-1760	1	39	to	to	ADP
aiua-1760	1	40	spontaneous	spontaneous	ADJ
aiua-1760	1	41	fluctuation	fluctuation	NOUN
aiua-1760	1	42	(	(	PUNCT
aiua-1760	1	43	1	1	NUM
aiua-1760	1	44	)	)	PUNCT
aiua-1760	1	45	,	,	PUNCT
aiua-1760	1	46	ejaculation	ejaculation	NOUN
aiua-1760	1	47	,	,	PUNCT
aiua-1760	1	48	bph	bph	NOUN
aiua-1760	1	49	and	and	CCONJ
aiua-1760	1	50	acute	acute	ADJ
aiua-1760	1	51	or	or	CCONJ
aiua-1760	1	52	subclinical	subclinical	ADJ
aiua-1760	1	53	chronic	chronic	ADJ
aiua-1760	1	54	prostatitis	prostatitis	NOUN
aiua-1760	1	55	(	(	PUNCT
aiua-1760	1	56	cp	cp	NOUN
aiua-1760	1	57	)	)	PUNCT
aiua-1760	1	58	.	.	PUNCT
aiua-1760	2	1	psa	psa	PROPN
aiua-1760	2	2	levels	level	NOUN
aiua-1760	2	3	have	have	AUX
aiua-1760	2	4	been	be	AUX
aiua-1760	2	5	correlated	correlate	VERB
aiua-1760	2	6	with	with	ADP
aiua-1760	2	7	the	the	DET
aiua-1760	2	8	extent	extent	NOUN
aiua-1760	2	9	and	and	CCONJ
aiua-1760	2	10	degree	degree	NOUN
aiua-1760	2	11	of	of	ADP
aiua-1760	2	12	inflammation	inflammation	NOUN
aiua-1760	2	13	(	(	PUNCT
aiua-1760	2	14	2	2	NUM
aiua-1760	2	15	,	,	PUNCT
aiua-1760	2	16	3	3	NUM
aiua-1760	2	17	)	)	PUNCT
aiua-1760	2	18	and	and	CCONJ
aiua-1760	2	19	a	a	DET
aiua-1760	2	20	short	short	ADJ
aiua-1760	2	21	trial	trial	NOUN
aiua-1760	2	22	of	of	ADP
aiua-1760	2	23	antibiotics	antibiotic	NOUN
aiua-1760	2	24	for	for	ADP
aiua-1760	2	25	a	a	DET
aiua-1760	2	26	likely	likely	ADJ
aiua-1760	2	27	subclinical	subclinical	ADJ
aiua-1760	2	28	cp	cp	INTJ
aiua-1760	2	29	has	have	VERB
aiua-1760	2	30	some	some	DET
aiua-1760	2	31	theoretical	theoretical	ADJ
aiua-1760	2	32	advantages	advantage	NOUN
aiua-1760	2	33	in	in	ADP
aiua-1760	2	34	decreasing	decrease	VERB
aiua-1760	2	35	psa	psa	NOUN
aiua-1760	2	36	levels	level	NOUN
aiua-1760	2	37	(	(	PUNCT
aiua-1760	2	38	34.6	34.6	NUM
aiua-1760	2	39	-	-	SYM
aiua-1760	2	40	56	56	NUM
aiua-1760	2	41	%	%	NOUN
aiua-1760	2	42	of	of	ADP
aiua-1760	2	43	the	the	DET
aiua-1760	2	44	cases	case	NOUN
aiua-1760	2	45	)	)	PUNCT
aiua-1760	2	46	(	(	PUNCT
aiua-1760	2	47	4	4	NUM
aiua-1760	2	48	,	,	PUNCT
aiua-1760	2	49	5	5	NUM
aiua-1760	2	50	)	)	PUNCT
aiua-1760	2	51	thus	thus	ADV
aiua-1760	2	52	minimizing	minimize	VERB
aiua-1760	2	53	the	the	DET
aiua-1760	2	54	number	number	NOUN
aiua-1760	2	55	of	of	ADP
aiua-1760	2	56	biopsies	biopsy	NOUN
aiua-1760	2	57	for	for	ADP
aiua-1760	2	58	falsely	falsely	ADV
aiua-1760	2	59	elevated	elevate	VERB
aiua-1760	2	60	psa	psa	NOUN
aiua-1760	2	61	(	(	PUNCT
aiua-1760	2	62	20	20	NUM
aiua-1760	2	63	-	-	SYM
aiua-1760	2	64	30	30	NUM
aiua-1760	2	65	%	%	NOUN
aiua-1760	2	66	of	of	ADP
aiua-1760	2	67	the	the	DET
aiua-1760	2	68	cases	case	NOUN
aiua-1760	2	69	)	)	PUNCT
aiua-1760	2	70	(	(	PUNCT
aiua-1760	2	71	6	6	NUM
aiua-1760	2	72	,	,	PUNCT
aiua-1760	2	73	7	7	NUM
aiua-1760	2	74	)	)	PUNCT
aiua-1760	2	75	.	.	PUNCT
aiua-1760	3	1	the	the	DET
aiua-1760	3	2	difference	difference	NOUN
aiua-1760	3	3	between	between	ADP
aiua-1760	3	4	pre	pre	ADJ
aiua-1760	3	5	and	and	CCONJ
aiua-1760	3	6	post	post	ADJ
aiua-1760	3	7	-	-	ADJ
aiua-1760	3	8	treatment	treatment	ADJ
aiua-1760	3	9	psa	psa	NOUN
aiua-1760	3	10	levels	level	NOUN
aiua-1760	3	11	appears	appear	VERB
aiua-1760	3	12	significant	significant	ADJ
aiua-1760	3	13	only	only	ADV
aiua-1760	3	14	in	in	ADP
aiua-1760	3	15	benign	benign	ADJ
aiua-1760	3	16	conditions	condition	NOUN
aiua-1760	3	17	(	(	PUNCT
aiua-1760	3	18	bph	bph	NOUN
aiua-1760	3	19	and	and	CCONJ
aiua-1760	3	20	prostatitis	prostatitis	NOUN
aiua-1760	3	21	cases	case	NOUN
aiua-1760	3	22	)	)	PUNCT
aiua-1760	3	23	while	while	SCONJ
aiua-1760	3	24	in	in	ADP
aiua-1760	3	25	histologically	histologically	NOUN
aiua-1760	3	26	proven	prove	VERB
aiua-1760	3	27	original	original	ADJ
aiua-1760	3	28	paper	paper	NOUN
aiua-1760	3	29	does	do	AUX
aiua-1760	3	30	prolonged	prolong	VERB
aiua-1760	3	31	anti	anti	ADJ
aiua-1760	3	32	-	-	ADJ
aiua-1760	3	33	inflammatory	inflammatory	ADJ
aiua-1760	3	34	therapy	therapy	NOUN
aiua-1760	3	35	reduce	reduce	VERB
aiua-1760	3	36	number	number	NOUN
aiua-1760	3	37	of	of	ADP
aiua-1760	3	38	unnecessary	unnecessary	ADJ
aiua-1760	3	39	repeat	repeat	NOUN
aiua-1760	3	40	saturation	saturation	NOUN
aiua-1760	3	41	prostate	prostate	NOUN
aiua-1760	3	42	biopsy	biopsy	NOUN
aiua-1760	3	43	?	?	PUNCT
aiua-1760	4	1	giuseppe	giuseppe	PROPN
aiua-1760	4	2	candiano	candiano	PROPN
aiua-1760	4	3	,	,	PUNCT
aiua-1760	4	4	pietro	pietro	PROPN
aiua-1760	4	5	pepe	pepe	PROPN
aiua-1760	4	6	,	,	PUNCT
aiua-1760	4	7	francesco	francesco	PROPN
aiua-1760	4	8	pietropaolo	pietropaolo	PROPN
aiua-1760	4	9	,	,	PUNCT
aiua-1760	4	10	francesco	francesco	PROPN
aiua-1760	4	11	aragona	aragona	PROPN
aiua-1760	4	12	urology	urology	NOUN
aiua-1760	4	13	unit	unit	NOUN
aiua-1760	4	14	cannizzaro	cannizzaro	NOUN
aiua-1760	4	15	hospital	hospital	PROPN
aiua-1760	4	16	,	,	PUNCT
aiua-1760	4	17	catania	catania	PROPN
aiua-1760	4	18	,	,	PUNCT
aiua-1760	4	19	italy	italy	PROPN
aiua-1760	4	20	.	.	PUNCT
aiua-1760	5	1	introduction	introduction	NOUN
aiua-1760	5	2	.	.	PUNCT
aiua-1760	6	1	the	the	DET
aiua-1760	6	2	effect	effect	NOUN
aiua-1760	6	3	of	of	ADP
aiua-1760	6	4	a	a	DET
aiua-1760	6	5	prolonged	prolonged	ADJ
aiua-1760	6	6	oral	oral	ADJ
aiua-1760	6	7	anti	anti	ADJ
aiua-1760	6	8	-	-	ADJ
aiua-1760	6	9	inflammatory	inflammatory	ADJ
aiua-1760	6	10	therapy	therapy	NOUN
aiua-1760	6	11	on	on	ADP
aiua-1760	6	12	psa	psa	NOUN
aiua-1760	6	13	values	value	NOUN
aiua-1760	6	14	in	in	ADP
aiua-1760	6	15	patients	patient	NOUN
aiua-1760	6	16	with	with	ADP
aiua-1760	6	17	persistent	persistent	ADJ
aiua-1760	6	18	abnormal	abnormal	ADJ
aiua-1760	6	19	psa	psa	NOUN
aiua-1760	6	20	values	value	NOUN
aiua-1760	6	21	after	after	SCONJ
aiua-1760	6	22	negative	negative	ADJ
aiua-1760	6	23	prostate	prostate	NOUN
aiua-1760	6	24	biopsy	biopsy	NOUN
aiua-1760	6	25	(	(	PUNCT
aiua-1760	6	26	pbx	pbx	PROPN
aiua-1760	6	27	)	)	PUNCT
aiua-1760	6	28	was	be	AUX
aiua-1760	6	29	evaluated	evaluate	VERB
aiua-1760	6	30	.	.	PUNCT
aiua-1760	7	1	material	material	NOUN
aiua-1760	7	2	and	and	CCONJ
aiua-1760	7	3	methods	method	NOUN
aiua-1760	7	4	.	.	PUNCT
aiua-1760	8	1	from	from	ADP
aiua-1760	8	2	september	september	PROPN
aiua-1760	8	3	2011	2011	NUM
aiua-1760	8	4	to	to	ADP
aiua-1760	8	5	september	september	PROPN
aiua-1760	8	6	2012	2012	NUM
aiua-1760	8	7	,	,	PUNCT
aiua-1760	8	8	70	70	NUM
aiua-1760	8	9	patients	patient	NOUN
aiua-1760	8	10	(	(	PUNCT
aiua-1760	8	11	median	median	ADJ
aiua-1760	8	12	age	age	NOUN
aiua-1760	8	13	62	62	NUM
aiua-1760	8	14	years	year	NOUN
aiua-1760	8	15	)	)	PUNCT
aiua-1760	8	16	,	,	PUNCT
aiua-1760	8	17	with	with	ADP
aiua-1760	8	18	persistent	persistent	ADJ
aiua-1760	8	19	abnormal	abnormal	ADJ
aiua-1760	8	20	psa	psa	NOUN
aiua-1760	8	21	values	value	NOUN
aiua-1760	8	22	after	after	ADP
aiua-1760	8	23	negative	negative	ADJ
aiua-1760	8	24	extended	extended	ADJ
aiua-1760	8	25	pbx	pbx	NOUN
aiua-1760	8	26	,	,	PUNCT
aiua-1760	8	27	were	be	AUX
aiua-1760	8	28	given	give	VERB
aiua-1760	8	29	an	an	DET
aiua-1760	8	30	herbal	herbal	ADJ
aiua-1760	8	31	extract	extract	NOUN
aiua-1760	8	32	with	with	ADP
aiua-1760	8	33	anti	anti	ADJ
aiua-1760	8	34	-	-	ADJ
aiua-1760	8	35	inflammatory	inflammatory	ADJ
aiua-1760	8	36	activity	activity	NOUN
aiua-1760	8	37	for	for	ADP
aiua-1760	8	38	3	3	NUM
aiua-1760	8	39	months	month	NOUN
aiua-1760	8	40	(	(	PUNCT
aiua-1760	8	41	lenidase	lenidase	PROPN
aiua-1760	8	42	®	®	NOUN
aiua-1760	8	43	;	;	PUNCT
aiua-1760	8	44	1	1	NUM
aiua-1760	8	45	tablet	tablet	NOUN
aiua-1760	8	46	daily	daily	PROPN
aiua-1760	8	47	constituted	constitute	VERB
aiua-1760	8	48	of	of	ADP
aiua-1760	8	49	baicalina	baicalina	PROPN
aiua-1760	8	50	,	,	PUNCT
aiua-1760	8	51	bromelina	bromelina	NOUN
aiua-1760	8	52	and	and	CCONJ
aiua-1760	8	53	escina	escina	ADJ
aiua-1760	8	54	)	)	PUNCT
aiua-1760	8	55	.	.	PUNCT
aiua-1760	9	1	all	all	DET
aiua-1760	9	2	patients	patient	NOUN
aiua-1760	9	3	were	be	AUX
aiua-1760	9	4	submitted	submit	VERB
aiua-1760	9	5	to	to	ADP
aiua-1760	9	6	prostate	prostate	NOUN
aiua-1760	9	7	biopsy	biopsy	NOUN
aiua-1760	9	8	for	for	ADP
aiua-1760	9	9	:	:	PUNCT
aiua-1760	9	10	abnormal	abnormal	ADJ
aiua-1760	9	11	dre	dre	NOUN
aiua-1760	9	12	;	;	PUNCT
aiua-1760	9	13	psa	psa	VERB
aiua-1760	9	14	>	>	X
aiua-1760	9	15	10	10	NUM
aiua-1760	9	16	ng	ng	PROPN
aiua-1760	9	17	/	/	SYM
aiua-1760	9	18	ml	ml	PROPN
aiua-1760	9	19	,	,	PUNCT
aiua-1760	9	20	psa	psa	VERB
aiua-1760	9	21	values	value	NOUN
aiua-1760	9	22	between	between	ADP
aiua-1760	9	23	4.1	4.1	NUM
aiua-1760	9	24	-	-	SYM
aiua-1760	9	25	10	10	NUM
aiua-1760	9	26	or	or	CCONJ
aiua-1760	9	27	2.6	2.6	NUM
aiua-1760	9	28	-	-	SYM
aiua-1760	9	29	4	4	NUM
aiua-1760	9	30	ng	ng	NOUN
aiua-1760	9	31	/	/	SYM
aiua-1760	9	32	ml	ml	X
aiua-1760	9	33	with	with	ADP
aiua-1760	9	34	free	free	ADJ
aiua-1760	9	35	/	/	SYM
aiua-1760	9	36	total	total	ADJ
aiua-1760	9	37	psa	psa	NOUN
aiua-1760	9	38	<	<	X
aiua-1760	9	39	25	25	NUM
aiua-1760	9	40	%	%	NOUN
aiua-1760	9	41	and	and	CCONJ
aiua-1760	9	42	<	<	X
aiua-1760	9	43	20	20	NUM
aiua-1760	9	44	%	%	NOUN
aiua-1760	9	45	,	,	PUNCT
aiua-1760	9	46	respectively	respectively	ADV
aiua-1760	9	47	.	.	PUNCT
aiua-1760	10	1	three	three	NUM
aiua-1760	10	2	months	month	NOUN
aiua-1760	10	3	after	after	ADP
aiua-1760	10	4	the	the	DET
aiua-1760	10	5	end	end	NOUN
aiua-1760	10	6	of	of	ADP
aiua-1760	10	7	anti	anti	ADJ
aiua-1760	10	8	-	-	ADJ
aiua-1760	10	9	inflammatory	inflammatory	ADJ
aiua-1760	10	10	therapy	therapy	NOUN
aiua-1760	10	11	all	all	DET
aiua-1760	10	12	patients	patient	NOUN
aiua-1760	10	13	were	be	AUX
aiua-1760	10	14	revaluated	revaluate	VERB
aiua-1760	10	15	;	;	PUNCT
aiua-1760	10	16	indication	indication	NOUN
aiua-1760	10	17	for	for	ADP
aiua-1760	10	18	repeat	repeat	NOUN
aiua-1760	10	19	saturation	saturation	NOUN
aiua-1760	10	20	biopsy	biopsy	NOUN
aiua-1760	10	21	(	(	PUNCT
aiua-1760	10	22	spbx	spbx	NOUN
aiua-1760	10	23	)	)	PUNCT
aiua-1760	10	24	and	and	CCONJ
aiua-1760	10	25	detection	detection	NOUN
aiua-1760	10	26	rate	rate	NOUN
aiua-1760	10	27	for	for	ADP
aiua-1760	10	28	pca	pca	PROPN
aiua-1760	10	29	were	be	AUX
aiua-1760	10	30	compared	compare	VERB
aiua-1760	10	31	with	with	ADP
aiua-1760	10	32	those	those	PRON
aiua-1760	10	33	previously	previously	ADV
aiua-1760	10	34	recorded	record	VERB
aiua-1760	10	35	in	in	ADP
aiua-1760	10	36	our	our	PRON
aiua-1760	10	37	department	department	NOUN
aiua-1760	10	38	using	use	VERB
aiua-1760	10	39	the	the	DET
aiua-1760	10	40	same	same	ADJ
aiua-1760	10	41	inclusions	inclusion	NOUN
aiua-1760	10	42	criteria	criterion	NOUN
aiua-1760	10	43	for	for	ADP
aiua-1760	10	44	biopsy	biopsy	NOUN
aiua-1760	10	45	.	.	PUNCT
aiua-1760	11	1	results	result	NOUN
aiua-1760	11	2	.	.	PUNCT
aiua-1760	12	1	oral	oral	ADJ
aiua-1760	12	2	administration	administration	NOUN
aiua-1760	12	3	of	of	ADP
aiua-1760	12	4	lenidase	lenidase	PROPN
aiua-1760	12	5	®	®	NOUN
aiua-1760	12	6	was	be	AUX
aiua-1760	12	7	well	well	ADV
aiua-1760	12	8	tolerated	tolerate	VERB
aiua-1760	12	9	and	and	CCONJ
aiua-1760	12	10	no	no	DET
aiua-1760	12	11	side	side	NOUN
aiua-1760	12	12	effects	effect	NOUN
aiua-1760	12	13	were	be	AUX
aiua-1760	12	14	observed	observe	VERB
aiua-1760	12	15	;	;	PUNCT
aiua-1760	12	16	psa	psa	VERB
aiua-1760	12	17	values	value	NOUN
aiua-1760	12	18	decreased	decrease	VERB
aiua-1760	12	19	in	in	ADP
aiua-1760	12	20	54	54	NUM
aiua-1760	12	21	(	(	PUNCT
aiua-1760	12	22	77.8	77.8	NUM
aiua-1760	12	23	%	%	NOUN
aiua-1760	12	24	)	)	PUNCT
aiua-1760	12	25	out	out	ADP
aiua-1760	12	26	70	70	NUM
aiua-1760	12	27	patients	patient	NOUN
aiua-1760	12	28	with	with	ADP
aiua-1760	12	29	a	a	DET
aiua-1760	12	30	median	median	ADJ
aiua-1760	12	31	psa	psa	NOUN
aiua-1760	12	32	reduction	reduction	NOUN
aiua-1760	12	33	of	of	ADP
aiua-1760	12	34	20.5	20.5	NUM
aiua-1760	12	35	%	%	NOUN
aiua-1760	12	36	(	(	PUNCT
aiua-1760	12	37	from	from	ADP
aiua-1760	12	38	8.8	8.8	NUM
aiua-1760	12	39	to	to	PART
aiua-1760	12	40	7	7	NUM
aiua-1760	12	41	ng	ng	PROPN
aiua-1760	12	42	/	/	SYM
aiua-1760	12	43	ml	ml	PROPN
aiua-1760	12	44	)	)	PUNCT
aiua-1760	12	45	and	and	CCONJ
aiua-1760	12	46	remained	remain	VERB
aiua-1760	12	47	unchanged	unchanged	ADJ
aiua-1760	12	48	in	in	ADP
aiua-1760	12	49	16	16	NUM
aiua-1760	12	50	patients	patient	NOUN
aiua-1760	12	51	(	(	PUNCT
aiua-1760	12	52	22.2	22.2	NUM
aiua-1760	12	53	%	%	NOUN
aiua-1760	12	54	)	)	PUNCT
aiua-1760	12	55	;	;	PUNCT
aiua-1760	12	56	the	the	DET
aiua-1760	12	57	repeat	repeat	NOUN
aiua-1760	12	58	spbx	spbx	PROPN
aiua-1760	12	59	rate	rate	NOUN
aiua-1760	12	60	resulted	result	VERB
aiua-1760	12	61	significantly	significantly	ADV
aiua-1760	12	62	lower	lower	ADV
aiua-1760	12	63	(	(	PUNCT
aiua-1760	12	64	22.8	22.8	NUM
aiua-1760	12	65	%	%	NOUN
aiua-1760	12	66	vs	vs	ADP
aiua-1760	12	67	35.5	35.5	NUM
aiua-1760	12	68	%	%	NOUN
aiua-1760	12	69	;	;	PUNCT
aiua-1760	12	70	p	p	X
aiua-1760	12	71	<	<	X
aiua-1760	12	72	0.05	0.05	NUM
aiua-1760	12	73	)	)	PUNCT
aiua-1760	12	74	showing	show	VERB
aiua-1760	12	75	a	a	DET
aiua-1760	12	76	superimposable	superimposable	ADJ
aiua-1760	12	77	detection	detection	NOUN
aiua-1760	12	78	rate	rate	NOUN
aiua-1760	12	79	for	for	ADP
aiua-1760	12	80	pca	pca	PROPN
aiua-1760	12	81	(	(	PUNCT
aiua-1760	12	82	3	3	NUM
aiua-1760	12	83	cases	case	NOUN
aiua-1760	12	84	)	)	PUNCT
aiua-1760	12	85	in	in	ADP
aiua-1760	12	86	comparison	comparison	NOUN
aiua-1760	12	87	with	with	ADP
aiua-1760	12	88	our	our	PRON
aiua-1760	12	89	previous	previous	ADJ
aiua-1760	12	90	data	datum	NOUN
aiua-1760	12	91	(	(	PUNCT
aiua-1760	12	92	18.7	18.7	NUM
aiua-1760	12	93	%	%	NOUN
aiua-1760	12	94	vs	vs	ADP
aiua-1760	12	95	22	22	NUM
aiua-1760	12	96	%	%	NOUN
aiua-1760	12	97	)	)	PUNCT
aiua-1760	12	98	.	.	PUNCT
aiua-1760	13	1	conclusions	conclusion	NOUN
aiua-1760	13	2	.	.	PUNCT
aiua-1760	14	1	in	in	ADP
aiua-1760	14	2	our	our	PRON
aiua-1760	14	3	preliminary	preliminary	ADJ
aiua-1760	14	4	data	datum	NOUN
aiua-1760	14	5	a	a	DET
aiua-1760	14	6	prolonged	prolonged	ADJ
aiua-1760	14	7	oral	oral	ADJ
aiua-1760	14	8	anti	anti	ADJ
aiua-1760	14	9	-	-	ADJ
aiua-1760	14	10	inflammatory	inflammatory	ADJ
aiua-1760	14	11	therapy	therapy	NOUN
aiua-1760	14	12	reduced	reduce	VERB
aiua-1760	14	13	psa	psa	NOUN
aiua-1760	14	14	levels	level	NOUN
aiua-1760	14	15	in	in	ADP
aiua-1760	14	16	patients	patient	NOUN
aiua-1760	14	17	with	with	ADP
aiua-1760	14	18	negative	negative	ADJ
aiua-1760	14	19	pbx	pbx	NOUN
aiua-1760	14	20	and	and	CCONJ
aiua-1760	14	21	persistent	persistent	ADJ
aiua-1760	14	22	suspicious	suspicious	ADJ
aiua-1760	14	23	for	for	ADP
aiua-1760	14	24	pca	pca	NOUN
aiua-1760	14	25	decreasing	decrease	VERB
aiua-1760	14	26	the	the	DET
aiua-1760	14	27	indication	indication	NOUN
aiua-1760	14	28	to	to	PART
aiua-1760	14	29	perform	perform	VERB
aiua-1760	14	30	repeat	repeat	NOUN
aiua-1760	14	31	spbx	spbx	NOUN
aiua-1760	14	32	(	(	PUNCT
aiua-1760	14	33	about	about	ADV
aiua-1760	14	34	30	30	NUM
aiua-1760	14	35	%	%	NOUN
aiua-1760	14	36	of	of	ADP
aiua-1760	14	37	the	the	DET
aiua-1760	14	38	cases	case	NOUN
aiua-1760	14	39	)	)	PUNCT
aiua-1760	14	40	.	.	PUNCT
aiua-1760	15	1	key	key	ADJ
aiua-1760	15	2	words	word	NOUN
aiua-1760	15	3	:	:	PUNCT
aiua-1760	15	4	prostate	prostate	NOUN
aiua-1760	15	5	cancer	cancer	NOUN
aiua-1760	15	6	;	;	PUNCT
aiua-1760	15	7	repeat	repeat	NOUN
aiua-1760	15	8	saturation	saturation	NOUN
aiua-1760	15	9	biopsy	biopsy	NOUN
aiua-1760	15	10	;	;	PUNCT
aiua-1760	15	11	prostatitis	prostatitis	NOUN
aiua-1760	15	12	;	;	PUNCT
aiua-1760	15	13	psa	psa	VERB
aiua-1760	15	14	;	;	PUNCT
aiua-1760	15	15	anti	anti	ADJ
aiua-1760	15	16	-	-	ADJ
aiua-1760	15	17	inflammatory	inflammatory	ADJ
aiua-1760	15	18	therapy	therapy	NOUN
aiua-1760	15	19	.	.	PUNCT
aiua-1760	15	20	submitted	submit	VERB
aiua-1760	15	21	24	24	NUM
aiua-1760	15	22	september	september	PROPN
aiua-1760	15	23	2012	2012	NUM
aiua-1760	15	24	;	;	PUNCT
aiua-1760	15	25	accepted	accept	VERB
aiua-1760	15	26	31	31	NUM
aiua-1760	15	27	december	december	PROPN
aiua-1760	15	28	2012	2012	NUM
aiua-1760	15	29	no	no	DET
aiua-1760	15	30	conflict	conflict	NOUN
aiua-1760	15	31	of	of	ADP
aiua-1760	15	32	interest	interest	NOUN
aiua-1760	15	33	declared	declare	VERB
aiua-1760	15	34	summary	summary	NOUN
aiua-1760	15	35	cancer	cancer	NOUN
aiua-1760	15	36	the	the	DET
aiua-1760	15	37	difference	difference	NOUN
aiua-1760	15	38	seems	seem	VERB
aiua-1760	15	39	unremarkable	unremarkable	ADJ
aiua-1760	15	40	(	(	PUNCT
aiua-1760	15	41	8)	8)	NUM
aiua-1760	15	42	.	.	PUNCT
aiua-1760	16	1	at	at	ADP
aiua-1760	16	2	the	the	DET
aiua-1760	16	3	same	same	ADJ
aiua-1760	16	4	time	time	NOUN
aiua-1760	16	5	,	,	PUNCT
aiua-1760	16	6	the	the	DET
aiua-1760	16	7	administration	administration	NOUN
aiua-1760	16	8	of	of	ADP
aiua-1760	16	9	nonsteroidal	nonsteroidal	NOUN
aiua-1760	16	10	antiinflammatory	antiinflammatory	NOUN
aiua-1760	16	11	drugs	drug	NOUN
aiua-1760	16	12	(	(	PUNCT
aiua-1760	16	13	nsaids	nsaid	NOUN
aiua-1760	16	14	)	)	PUNCT
aiua-1760	16	15	or	or	CCONJ
aiua-1760	16	16	aspirin	aspirin	NOUN
aiua-1760	16	17	,	,	PUNCT
aiua-1760	16	18	blocking	block	VERB
aiua-1760	16	19	the	the	DET
aiua-1760	16	20	cyclooxygenase	cyclooxygenase	NOUN
aiua-1760	16	21	(	(	PUNCT
aiua-1760	16	22	cox	cox	NOUN
aiua-1760	16	23	)	)	PUNCT
aiua-1760	16	24	activity	activity	NOUN
aiua-1760	16	25	(	(	PUNCT
aiua-1760	16	26	a	a	DET
aiua-1760	16	27	strong	strong	ADJ
aiua-1760	16	28	mediator	mediator	NOUN
aiua-1760	16	29	of	of	ADP
aiua-1760	16	30	inflammation	inflammation	NOUN
aiua-1760	16	31	)	)	PUNCT
aiua-1760	16	32	,	,	PUNCT
aiua-1760	16	33	could	could	AUX
aiua-1760	16	34	have	have	VERB
aiua-1760	16	35	a	a	DET
aiua-1760	16	36	potential	potential	ADJ
aiua-1760	16	37	role	role	NOUN
aiua-1760	16	38	in	in	ADP
aiua-1760	16	39	decreasing	decrease	VERB
aiua-1760	16	40	psa	psa	NOUN
aiua-1760	16	41	values	value	NOUN
aiua-1760	16	42	.	.	PUNCT
aiua-1760	17	1	however	however	ADV
aiua-1760	17	2	,	,	PUNCT
aiua-1760	17	3	the	the	DET
aiua-1760	17	4	relationship	relationship	NOUN
aiua-1760	17	5	between	between	ADP
aiua-1760	17	6	oral	oral	ADJ
aiua-1760	17	7	nsaids	nsaid	NOUN
aiua-1760	17	8	consumption	consumption	NOUN
aiua-1760	17	9	,	,	PUNCT
aiua-1760	17	10	psa	psa	NOUN
aiua-1760	17	11	levels	level	NOUN
aiua-1760	17	12	and	and	CCONJ
aiua-1760	17	13	pca	pca	NOUN
aiua-1760	17	14	risk	risk	NOUN
aiua-1760	17	15	is	be	AUX
aiua-1760	17	16	unknown	unknown	ADJ
aiua-1760	17	17	(	(	PUNCT
aiua-1760	17	18	9	9	NUM
aiua-1760	17	19	)	)	PUNCT
aiua-1760	17	20	.	.	PUNCT
aiua-1760	18	1	in	in	ADP
aiua-1760	18	2	this	this	DET
aiua-1760	18	3	prospective	prospective	ADJ
aiua-1760	18	4	study	study	NOUN
aiua-1760	18	5	we	we	PRON
aiua-1760	18	6	evaluated	evaluate	VERB
aiua-1760	18	7	,	,	PUNCT
aiua-1760	18	8	in	in	ADP
aiua-1760	18	9	patients	patient	NOUN
aiua-1760	18	10	with	with	ADP
aiua-1760	18	11	negative	negative	ADJ
aiua-1760	18	12	extended	extended	ADJ
aiua-1760	18	13	prostate	prostate	NOUN
aiua-1760	18	14	biopsy	biopsy	NOUN
aiua-1760	18	15	and	and	CCONJ
aiua-1760	18	16	persistent	persistent	ADJ
aiua-1760	18	17	abnormal	abnormal	ADJ
aiua-1760	18	18	psa	psa	NOUN
aiua-1760	18	19	values	value	NOUN
aiua-1760	18	20	,	,	PUNCT
aiua-1760	18	21	the	the	DET
aiua-1760	18	22	effect	effect	NOUN
aiua-1760	18	23	of	of	ADP
aiua-1760	18	24	a	a	DET
aiua-1760	18	25	prolonged	prolonged	ADJ
aiua-1760	18	26	oral	oral	ADJ
aiua-1760	18	27	antiinflammatory	antiinflammatory	NOUN
aiua-1760	18	28	therapy	therapy	NOUN
aiua-1760	18	29	on	on	ADP
aiua-1760	18	30	psa	psa	NOUN
aiua-1760	18	31	values	value	NOUN
aiua-1760	18	32	in	in	ADP
aiua-1760	18	33	order	order	NOUN
aiua-1760	18	34	to	to	PART
aiua-1760	18	35	reduce	reduce	VERB
aiua-1760	18	36	the	the	DET
aiua-1760	18	37	number	number	NOUN
aiua-1760	18	38	of	of	ADP
aiua-1760	18	39	unnecessary	unnecessary	ADJ
aiua-1760	18	40	repeat	repeat	NOUN
aiua-1760	18	41	biopsies	biopsy	NOUN
aiua-1760	18	42	.	.	PUNCT
aiua-1760	19	1	candiano_stesura	candiano_stesura	ADJ
aiua-1760	19	2	seveso	seveso	VERB
aiua-1760	19	3	24/06/13	24/06/13	PROPN
aiua-1760	19	4	10:59	10:59	NUM
aiua-1760	19	5	pagina	pagina	NOUN
aiua-1760	19	6	65	65	NUM
aiua-1760	19	7	archivio	archivio	NOUN
aiua-1760	19	8	italiano	italiano	X
aiua-1760	19	9	di	di	X
aiua-1760	19	10	urologia	urologia	PROPN
aiua-1760	19	11	e	e	PROPN
aiua-1760	19	12	andrologia	andrologia	NOUN
aiua-1760	19	13	2013	2013	NUM
aiua-1760	19	14	;	;	PUNCT
aiua-1760	19	15	85	85	NUM
aiua-1760	19	16	,	,	PUNCT
aiua-1760	19	17	2	2	NUM
aiua-1760	19	18	g.	g.	NOUN
aiua-1760	19	19	candiano	candiano	PROPN
aiua-1760	19	20	,	,	PUNCT
aiua-1760	19	21	p.	p.	PROPN
aiua-1760	19	22	pepe	pepe	PROPN
aiua-1760	19	23	,	,	PUNCT
aiua-1760	19	24	f.	f.	PROPN
aiua-1760	19	25	pietropaolo	pietropaolo	PROPN
aiua-1760	19	26	,	,	PUNCT
aiua-1760	19	27	f.	f.	PROPN
aiua-1760	19	28	aragona	aragona	PROPN
aiua-1760	19	29	66	66	NUM
aiua-1760	19	30	ously	ously	ADV
aiua-1760	19	31	recorded	record	VERB
aiua-1760	19	32	in	in	ADP
aiua-1760	19	33	our	our	PRON
aiua-1760	19	34	department	department	NOUN
aiua-1760	19	35	using	use	VERB
aiua-1760	19	36	the	the	DET
aiua-1760	19	37	same	same	ADJ
aiua-1760	19	38	inclusions	inclusion	NOUN
aiua-1760	19	39	criteria	criterion	NOUN
aiua-1760	19	40	for	for	ADP
aiua-1760	19	41	biopsy	biopsy	NOUN
aiua-1760	19	42	.	.	PUNCT
aiua-1760	20	1	finally	finally	ADV
aiua-1760	20	2	,	,	PUNCT
aiua-1760	20	3	a	a	DET
aiua-1760	20	4	p	p	NOUN
aiua-1760	20	5	value	value	NOUN
aiua-1760	20	6	<	<	X
aiua-1760	20	7	0.05	0.05	NUM
aiua-1760	20	8	was	be	AUX
aiua-1760	20	9	considered	consider	VERB
aiua-1760	20	10	statistically	statistically	ADV
aiua-1760	20	11	significant	significant	ADJ
aiua-1760	20	12	.	.	PUNCT
aiua-1760	21	1	results	result	VERB
aiua-1760	21	2	oral	oral	ADJ
aiua-1760	21	3	administration	administration	NOUN
aiua-1760	21	4	of	of	ADP
aiua-1760	21	5	lenidase	lenidase	PROPN
aiua-1760	21	6	®	®	NOUN
aiua-1760	21	7	was	be	AUX
aiua-1760	21	8	well	well	ADV
aiua-1760	21	9	tolerated	tolerate	VERB
aiua-1760	21	10	and	and	CCONJ
aiua-1760	21	11	no	no	DET
aiua-1760	21	12	side	side	NOUN
aiua-1760	21	13	effects	effect	NOUN
aiua-1760	21	14	were	be	AUX
aiua-1760	21	15	observed	observe	VERB
aiua-1760	21	16	.	.	PUNCT
aiua-1760	22	1	among	among	ADP
aiua-1760	22	2	70	70	NUM
aiua-1760	22	3	patients	patient	NOUN
aiua-1760	22	4	enrolled	enrol	VERB
aiua-1760	22	5	,	,	PUNCT
aiua-1760	22	6	psa	psa	VERB
aiua-1760	22	7	values	value	NOUN
aiua-1760	22	8	decreased	decrease	VERB
aiua-1760	22	9	after	after	ADP
aiua-1760	22	10	anti	anti	ADJ
aiua-1760	22	11	-	-	ADJ
aiua-1760	22	12	inflammatory	inflammatory	ADJ
aiua-1760	22	13	therapy	therapy	NOUN
aiua-1760	22	14	in	in	ADP
aiua-1760	22	15	54	54	NUM
aiua-1760	22	16	(	(	PUNCT
aiua-1760	22	17	77.8	77.8	NUM
aiua-1760	22	18	%	%	NOUN
aiua-1760	22	19	)	)	PUNCT
aiua-1760	22	20	with	with	ADP
aiua-1760	22	21	a	a	DET
aiua-1760	22	22	median	median	ADJ
aiua-1760	22	23	psa	psa	NOUN
aiua-1760	22	24	reduction	reduction	NOUN
aiua-1760	22	25	of	of	ADP
aiua-1760	22	26	20.5	20.5	NUM
aiua-1760	22	27	%	%	NOUN
aiua-1760	22	28	(	(	PUNCT
aiua-1760	22	29	from	from	ADP
aiua-1760	22	30	8.8	8.8	NUM
aiua-1760	22	31	to	to	PART
aiua-1760	22	32	7	7	NUM
aiua-1760	22	33	ng	ng	PROPN
aiua-1760	22	34	/	/	SYM
aiua-1760	22	35	ml	ml	PROPN
aiua-1760	22	36	)	)	PUNCT
aiua-1760	22	37	and	and	CCONJ
aiua-1760	22	38	remained	remain	VERB
aiua-1760	22	39	unchanged	unchanged	ADJ
aiua-1760	22	40	in	in	ADP
aiua-1760	22	41	the	the	DET
aiua-1760	22	42	remaining	remain	VERB
aiua-1760	22	43	16	16	NUM
aiua-1760	22	44	patients	patient	NOUN
aiua-1760	22	45	(	(	PUNCT
aiua-1760	22	46	22.2	22.2	NUM
aiua-1760	22	47	%	%	NOUN
aiua-1760	22	48	)	)	PUNCT
aiua-1760	22	49	.	.	PUNCT
aiua-1760	23	1	clinical	clinical	ADJ
aiua-1760	23	2	parameters	parameter	NOUN
aiua-1760	23	3	and	and	CCONJ
aiua-1760	23	4	serum	serum	NOUN
aiua-1760	23	5	exams	exam	NOUN
aiua-1760	23	6	before	before	ADP
aiua-1760	23	7	and	and	CCONJ
aiua-1760	23	8	after	after	ADP
aiua-1760	23	9	lenidase	lenidase	PROPN
aiua-1760	23	10	®	®	NOUN
aiua-1760	23	11	administration	administration	NOUN
aiua-1760	23	12	are	be	AUX
aiua-1760	23	13	listed	list	VERB
aiua-1760	23	14	in	in	ADP
aiua-1760	23	15	table	table	NOUN
aiua-1760	23	16	1	1	NUM
aiua-1760	23	17	.	.	PUNCT
aiua-1760	24	1	all	all	DET
aiua-1760	24	2	16	16	NUM
aiua-1760	24	3	patients	patient	NOUN
aiua-1760	24	4	whose	whose	DET
aiua-1760	24	5	psa	psa	NOUN
aiua-1760	24	6	did	do	AUX
aiua-1760	24	7	not	not	PART
aiua-1760	24	8	decrease	decrease	VERB
aiua-1760	24	9	after	after	ADP
aiua-1760	24	10	therapy	therapy	NOUN
aiua-1760	24	11	underwent	underwent	NOUN
aiua-1760	24	12	repeat	repeat	NOUN
aiua-1760	24	13	spbx	spbx	NOUN
aiua-1760	24	14	(	(	PUNCT
aiua-1760	24	15	6	6	NUM
aiua-1760	24	16	had	have	VERB
aiua-1760	24	17	a	a	DET
aiua-1760	24	18	psa	psa	NOUN
aiua-1760	24	19	included	include	VERB
aiua-1760	24	20	between	between	ADP
aiua-1760	24	21	4	4	NUM
aiua-1760	24	22	-	-	SYM
aiua-1760	24	23	10	10	NUM
aiua-1760	24	24	ng	ng	PROPN
aiua-1760	24	25	/	/	SYM
aiua-1760	24	26	ml	ml	PROPN
aiua-1760	24	27	and	and	CCONJ
aiua-1760	24	28	10	10	NUM
aiua-1760	24	29	greater	great	ADJ
aiua-1760	24	30	than	than	ADP
aiua-1760	24	31	10	10	NUM
aiua-1760	24	32	ng	ng	PROPN
aiua-1760	24	33	/	/	SYM
aiua-1760	24	34	ml	ml	PROPN
aiua-1760	24	35	)	)	PUNCT
aiua-1760	24	36	and	and	CCONJ
aiua-1760	24	37	in	in	ADP
aiua-1760	24	38	3	3	NUM
aiua-1760	24	39	of	of	ADP
aiua-1760	24	40	them	they	PRON
aiua-1760	24	41	a	a	DET
aiua-1760	24	42	cancer	cancer	NOUN
aiua-1760	24	43	was	be	AUX
aiua-1760	24	44	found	find	VERB
aiua-1760	24	45	(	(	PUNCT
aiua-1760	24	46	all	all	DET
aiua-1760	24	47	these	these	DET
aiua-1760	24	48	men	man	NOUN
aiua-1760	24	49	had	have	VERB
aiua-1760	24	50	one	one	NUM
aiua-1760	24	51	previous	previous	ADJ
aiua-1760	24	52	negative	negative	ADJ
aiua-1760	24	53	biopsy	biopsy	NOUN
aiua-1760	24	54	and	and	CCONJ
aiua-1760	24	55	a	a	DET
aiua-1760	24	56	psa	psa	NOUN
aiua-1760	24	57	>	>	X
aiua-1760	24	58	10	10	NUM
aiua-1760	24	59	ng	ng	PROPN
aiua-1760	24	60	/	/	SYM
aiua-1760	24	61	ml	ml	PROPN
aiua-1760	24	62	)	)	PUNCT
aiua-1760	24	63	.	.	PUNCT
aiua-1760	25	1	the	the	DET
aiua-1760	25	2	incidence	incidence	NOUN
aiua-1760	25	3	of	of	ADP
aiua-1760	25	4	repeat	repeat	NOUN
aiua-1760	25	5	biopsy	biopsy	NOUN
aiua-1760	25	6	in	in	ADP
aiua-1760	25	7	the	the	DET
aiua-1760	25	8	patients	patient	NOUN
aiua-1760	25	9	submitted	submit	VERB
aiua-1760	25	10	to	to	ADP
aiua-1760	25	11	anti	anti	ADJ
aiua-1760	25	12	-	-	ADJ
aiua-1760	25	13	inflammatory	inflammatory	ADJ
aiua-1760	25	14	therapy	therapy	NOUN
aiua-1760	25	15	resulted	result	VERB
aiua-1760	25	16	significantly	significantly	ADV
aiua-1760	25	17	lower	low	ADJ
aiua-1760	25	18	in	in	ADP
aiua-1760	25	19	comparison	comparison	NOUN
aiua-1760	25	20	with	with	ADP
aiua-1760	25	21	our	our	PRON
aiua-1760	25	22	previous	previous	ADJ
aiua-1760	25	23	data	datum	NOUN
aiua-1760	25	24	(	(	PUNCT
aiua-1760	25	25	22.8	22.8	NUM
aiua-1760	25	26	%	%	NOUN
aiua-1760	25	27	vs	vs	ADP
aiua-1760	25	28	35.5	35.5	NUM
aiua-1760	25	29	%	%	NOUN
aiua-1760	25	30	)	)	PUNCT
aiua-1760	25	31	(	(	PUNCT
aiua-1760	25	32	p	p	X
aiua-1760	25	33	<	<	X
aiua-1760	25	34	0.05	0.05	NUM
aiua-1760	25	35	)	)	PUNCT
aiua-1760	25	36	,	,	PUNCT
aiua-1760	25	37	respectively	respectively	ADV
aiua-1760	25	38	;	;	PUNCT
aiua-1760	25	39	on	on	ADP
aiua-1760	25	40	the	the	DET
aiua-1760	25	41	contrary	contrary	NOUN
aiua-1760	25	42	,	,	PUNCT
aiua-1760	25	43	the	the	DET
aiua-1760	25	44	detection	detection	NOUN
aiua-1760	25	45	rate	rate	NOUN
aiua-1760	25	46	for	for	ADP
aiua-1760	25	47	pca	pca	PROPN
aiua-1760	25	48	was	be	AUX
aiua-1760	25	49	superimposable	superimposable	ADJ
aiua-1760	25	50	(	(	PUNCT
aiua-1760	25	51	18.7	18.7	NUM
aiua-1760	25	52	%	%	NOUN
aiua-1760	25	53	vs	vs	ADP
aiua-1760	25	54	22	22	NUM
aiua-1760	25	55	%	%	NOUN
aiua-1760	25	56	)	)	PUNCT
aiua-1760	25	57	at	at	ADP
aiua-1760	25	58	repeat	repeat	PROPN
aiua-1760	25	59	spbx	spbx	PROPN
aiua-1760	25	60	.	.	PUNCT
aiua-1760	26	1	ipss	ipss	PROPN
aiua-1760	26	2	and	and	CCONJ
aiua-1760	26	3	qmax	qmax	PROPN
aiua-1760	26	4	values	value	NOUN
aiua-1760	26	5	were	be	AUX
aiua-1760	26	6	superimposable	superimposable	ADJ
aiua-1760	26	7	before	before	ADV
aiua-1760	26	8	and	and	CCONJ
aiua-1760	26	9	after	after	ADP
aiua-1760	26	10	anti	anti	ADJ
aiua-1760	26	11	-	-	ADJ
aiua-1760	26	12	inflammatory	inflammatory	ADJ
aiua-1760	26	13	therapy	therapy	NOUN
aiua-1760	26	14	(	(	PUNCT
aiua-1760	26	15	p	p	X
aiua-1760	26	16	>	>	X
aiua-1760	26	17	0.05	0.05	NUM
aiua-1760	26	18	)	)	PUNCT
aiua-1760	26	19	(	(	PUNCT
aiua-1760	26	20	table	table	NOUN
aiua-1760	26	21	1	1	NUM
aiua-1760	26	22	)	)	PUNCT
aiua-1760	26	23	.	.	PUNCT
aiua-1760	27	1	discussion	discussion	NOUN
aiua-1760	27	2	repeat	repeat	NOUN
aiua-1760	27	3	prostate	prostate	NOUN
aiua-1760	27	4	biopsy	biopsy	NOUN
aiua-1760	27	5	constitutes	constitute	VERB
aiua-1760	27	6	about	about	ADV
aiua-1760	27	7	30	30	NUM
aiua-1760	27	8	%	%	NOUN
aiua-1760	27	9	of	of	ADP
aiua-1760	27	10	all	all	DET
aiua-1760	27	11	the	the	DET
aiua-1760	27	12	procedures	procedure	NOUN
aiua-1760	27	13	with	with	ADP
aiua-1760	27	14	an	an	DET
aiua-1760	27	15	estimated	estimate	VERB
aiua-1760	27	16	detection	detection	NOUN
aiua-1760	27	17	rate	rate	NOUN
aiua-1760	27	18	for	for	ADP
aiua-1760	27	19	pca	pca	PROPN
aiua-1760	27	20	equal	equal	ADJ
aiua-1760	27	21	,	,	PUNCT
aiua-1760	27	22	in	in	ADP
aiua-1760	27	23	our	our	PRON
aiua-1760	27	24	experience	experience	NOUN
aiua-1760	27	25	,	,	PUNCT
aiua-1760	27	26	to	to	ADP
aiua-1760	27	27	20	20	NUM
aiua-1760	27	28	%	%	NOUN
aiua-1760	27	29	and	and	CCONJ
aiua-1760	27	30	6	6	NUM
aiua-1760	27	31	%	%	NOUN
aiua-1760	27	32	at	at	ADP
aiua-1760	27	33	second	second	ADJ
aiua-1760	27	34	and	and	CCONJ
aiua-1760	27	35	third	third	ADJ
aiua-1760	27	36	spbx	spbx	NOUN
aiua-1760	27	37	(	(	PUNCT
aiua-1760	27	38	10	10	NUM
aiua-1760	27	39	)	)	PUNCT
aiua-1760	27	40	,	,	PUNCT
aiua-1760	27	41	respectively	respectively	ADV
aiua-1760	27	42	;	;	PUNCT
aiua-1760	27	43	today	today	NOUN
aiua-1760	27	44	,	,	PUNCT
aiua-1760	27	45	the	the	DET
aiua-1760	27	46	main	main	ADJ
aiua-1760	27	47	goal	goal	NOUN
aiua-1760	27	48	of	of	ADP
aiua-1760	27	49	any	any	DET
aiua-1760	27	50	early	early	ADJ
aiua-1760	27	51	diagnosis	diagnosis	NOUN
aiua-1760	27	52	protocol	protocol	NOUN
aiua-1760	27	53	should	should	AUX
aiua-1760	27	54	be	be	AUX
aiua-1760	27	55	to	to	PART
aiua-1760	27	56	reduce	reduce	VERB
aiua-1760	27	57	the	the	DET
aiua-1760	27	58	number	number	NOUN
aiua-1760	27	59	of	of	ADP
aiua-1760	27	60	unnecessary	unnecessary	ADJ
aiua-1760	27	61	spbx	spbx	NOUN
aiua-1760	27	62	due	due	ADP
aiua-1760	27	63	to	to	ADP
aiua-1760	27	64	false	false	ADJ
aiua-1760	27	65	positive	positive	ADJ
aiua-1760	27	66	psa	psa	NOUN
aiua-1760	27	67	levels	level	NOUN
aiua-1760	27	68	.	.	PUNCT
aiua-1760	28	1	the	the	DET
aiua-1760	28	2	intra	intra	ADJ
aiua-1760	28	3	-	-	ADJ
aiua-1760	28	4	individual	individual	ADJ
aiua-1760	28	5	(	(	PUNCT
aiua-1760	28	6	physiological	physiological	ADJ
aiua-1760	28	7	)	)	PUNCT
aiua-1760	28	8	variation	variation	NOUN
aiua-1760	28	9	of	of	ADP
aiua-1760	28	10	psa	psa	NOUN
aiua-1760	28	11	in	in	ADP
aiua-1760	28	12	men	man	NOUN
aiua-1760	28	13	with	with	ADP
aiua-1760	28	14	benign	benign	ADJ
aiua-1760	28	15	prostate	prostate	NOUN
aiua-1760	28	16	biopsy	biopsy	NOUN
aiua-1760	28	17	is	be	AUX
aiua-1760	28	18	equal	equal	ADJ
aiua-1760	28	19	to	to	ADP
aiua-1760	28	20	9.5	9.5	NUM
aiua-1760	28	21	%	%	NOUN
aiua-1760	28	22	(	(	PUNCT
aiua-1760	28	23	12	12	NUM
aiua-1760	28	24	)	)	PUNCT
aiua-1760	28	25	;	;	PUNCT
aiua-1760	28	26	moreover	moreover	ADV
aiua-1760	28	27	,	,	PUNCT
aiua-1760	28	28	many	many	ADJ
aiua-1760	28	29	common	common	ADJ
aiua-1760	28	30	medications	medication	NOUN
aiua-1760	28	31	have	have	VERB
aiua-1760	28	32	an	an	DET
aiua-1760	28	33	effect	effect	NOUN
aiua-1760	28	34	on	on	ADP
aiua-1760	28	35	serum	serum	NOUN
aiua-1760	28	36	psa	psa	NOUN
aiua-1760	28	37	levels	level	NOUN
aiua-1760	28	38	:	:	PUNCT
aiua-1760	29	1	nsaids	nsaid	NOUN
aiua-1760	29	2	,	,	PUNCT
aiua-1760	29	3	thiazide	thiazide	ADP
aiua-1760	29	4	diuretics	diuretic	NOUN
aiua-1760	29	5	and	and	CCONJ
aiua-1760	29	6	statins	statin	NOUN
aiua-1760	29	7	reduce	reduce	VERB
aiua-1760	29	8	psa	psa	NOUN
aiua-1760	29	9	levels	level	NOUN
aiua-1760	29	10	from	from	ADP
aiua-1760	29	11	6	6	NUM
aiua-1760	29	12	%	%	NOUN
aiua-1760	29	13	to	to	PART
aiua-1760	29	14	26	26	NUM
aiua-1760	29	15	%	%	NOUN
aiua-1760	29	16	and	and	CCONJ
aiua-1760	29	17	the	the	DET
aiua-1760	29	18	combination	combination	NOUN
aiua-1760	29	19	of	of	ADP
aiua-1760	29	20	statins	statin	NOUN
aiua-1760	29	21	with	with	ADP
aiua-1760	29	22	thiazide	thiazide	ADJ
aiua-1760	29	23	diuretics	diuretic	NOUN
aiua-1760	29	24	could	could	AUX
aiua-1760	29	25	decrease	decrease	VERB
aiua-1760	29	26	psa	psa	VERB
aiua-1760	29	27	levmaterial	levmaterial	ADJ
aiua-1760	29	28	and	and	CCONJ
aiua-1760	29	29	methods	method	NOUN
aiua-1760	29	30	from	from	ADP
aiua-1760	29	31	september	september	PROPN
aiua-1760	29	32	2011	2011	NUM
aiua-1760	29	33	to	to	ADP
aiua-1760	29	34	september	september	PROPN
aiua-1760	29	35	2012	2012	NUM
aiua-1760	29	36	,	,	PUNCT
aiua-1760	29	37	70	70	NUM
aiua-1760	29	38	patients	patient	NOUN
aiua-1760	29	39	(	(	PUNCT
aiua-1760	29	40	median	median	ADJ
aiua-1760	29	41	age	age	NOUN
aiua-1760	29	42	62	62	NUM
aiua-1760	29	43	years	year	NOUN
aiua-1760	29	44	;	;	PUNCT
aiua-1760	29	45	range	range	NOUN
aiua-1760	29	46	:	:	PUNCT
aiua-1760	29	47	49	49	NUM
aiua-1760	29	48	-	-	SYM
aiua-1760	29	49	72	72	NUM
aiua-1760	29	50	years	year	NOUN
aiua-1760	29	51	)	)	PUNCT
aiua-1760	29	52	,	,	PUNCT
aiua-1760	29	53	with	with	ADP
aiua-1760	29	54	previous	previous	ADJ
aiua-1760	29	55	negative	negative	ADJ
aiua-1760	29	56	extended	extended	ADJ
aiua-1760	29	57	prostate	prostate	NOUN
aiua-1760	29	58	biopsy	biopsy	NOUN
aiua-1760	29	59	and	and	CCONJ
aiua-1760	29	60	persistent	persistent	ADJ
aiua-1760	29	61	abnormal	abnormal	ADJ
aiua-1760	29	62	psa	psa	NOUN
aiua-1760	29	63	values	value	NOUN
aiua-1760	29	64	,	,	PUNCT
aiua-1760	29	65	were	be	AUX
aiua-1760	29	66	given	give	VERB
aiua-1760	29	67	an	an	DET
aiua-1760	29	68	herbal	herbal	ADJ
aiua-1760	29	69	extract	extract	NOUN
aiua-1760	29	70	with	with	ADP
aiua-1760	29	71	antiinflammatory	antiinflammatory	NOUN
aiua-1760	29	72	activity	activity	NOUN
aiua-1760	29	73	(	(	PUNCT
aiua-1760	29	74	lenidase	lenidase	PROPN
aiua-1760	29	75	®	®	NOUN
aiua-1760	29	76	,	,	PUNCT
aiua-1760	29	77	1	1	NUM
aiua-1760	29	78	tablet	tablet	NOUN
aiua-1760	29	79	daily	daily	ADV
aiua-1760	29	80	)	)	PUNCT
aiua-1760	29	81	for	for	ADP
aiua-1760	29	82	3	3	NUM
aiua-1760	29	83	months	month	NOUN
aiua-1760	29	84	.	.	PUNCT
aiua-1760	30	1	all	all	DET
aiua-1760	30	2	patients	patient	NOUN
aiua-1760	30	3	,	,	PUNCT
aiua-1760	30	4	2	2	NUM
aiua-1760	30	5	months	month	NOUN
aiua-1760	30	6	before	before	ADP
aiua-1760	30	7	assuming	assume	VERB
aiua-1760	30	8	the	the	DET
aiua-1760	30	9	herbal	herbal	ADJ
aiua-1760	30	10	extract	extract	NOUN
aiua-1760	30	11	,	,	PUNCT
aiua-1760	30	12	underwent	underwent	ADJ
aiua-1760	30	13	prostate	prostate	NOUN
aiua-1760	30	14	biopsy	biopsy	NOUN
aiua-1760	30	15	for	for	ADP
aiua-1760	30	16	:	:	PUNCT
aiua-1760	30	17	abnormal	abnormal	ADJ
aiua-1760	30	18	digital	digital	ADJ
aiua-1760	30	19	rectal	rectal	ADJ
aiua-1760	30	20	examination	examination	NOUN
aiua-1760	30	21	(	(	PUNCT
aiua-1760	30	22	dre	dre	PROPN
aiua-1760	30	23	)	)	PUNCT
aiua-1760	30	24	;	;	PUNCT
aiua-1760	30	25	psa	psa	VERB
aiua-1760	30	26	>	>	X
aiua-1760	30	27	10	10	NUM
aiua-1760	30	28	ng	ng	PROPN
aiua-1760	30	29	/	/	SYM
aiua-1760	30	30	ml	ml	PROPN
aiua-1760	30	31	,	,	PUNCT
aiua-1760	30	32	psa	psa	VERB
aiua-1760	30	33	values	value	NOUN
aiua-1760	30	34	between	between	ADP
aiua-1760	30	35	4.1	4.1	NUM
aiua-1760	30	36	-	-	SYM
aiua-1760	30	37	10	10	NUM
aiua-1760	30	38	or	or	CCONJ
aiua-1760	30	39	2.6	2.6	NUM
aiua-1760	30	40	-	-	SYM
aiua-1760	30	41	4	4	NUM
aiua-1760	30	42	ng	ng	NOUN
aiua-1760	30	43	/	/	SYM
aiua-1760	30	44	ml	ml	X
aiua-1760	30	45	with	with	ADP
aiua-1760	30	46	free	free	ADJ
aiua-1760	30	47	/	/	SYM
aiua-1760	30	48	total	total	ADJ
aiua-1760	30	49	psa	psa	NOUN
aiua-1760	30	50	<	<	X
aiua-1760	30	51	25	25	NUM
aiua-1760	30	52	%	%	NOUN
aiua-1760	30	53	and	and	CCONJ
aiua-1760	30	54	<	<	X
aiua-1760	30	55	20	20	NUM
aiua-1760	30	56	%	%	NOUN
aiua-1760	30	57	,	,	PUNCT
aiua-1760	30	58	respectively	respectively	ADV
aiua-1760	30	59	according	accord	VERB
aiua-1760	30	60	to	to	ADP
aiua-1760	30	61	our	our	PRON
aiua-1760	30	62	early	early	ADJ
aiua-1760	30	63	diagnosis	diagnosis	NOUN
aiua-1760	30	64	protocol	protocol	NOUN
aiua-1760	30	65	(	(	PUNCT
aiua-1760	30	66	10	10	NUM
aiua-1760	30	67	)	)	PUNCT
aiua-1760	30	68	.	.	PUNCT
aiua-1760	31	1	the	the	DET
aiua-1760	31	2	biopsy	biopsy	NOUN
aiua-1760	31	3	was	be	AUX
aiua-1760	31	4	performed	perform	VERB
aiua-1760	31	5	by	by	ADP
aiua-1760	31	6	transperineal	transperineal	NOUN
aiua-1760	31	7	approach	approach	NOUN
aiua-1760	31	8	using	use	VERB
aiua-1760	31	9	a	a	DET
aiua-1760	31	10	18	18	NUM
aiua-1760	31	11	g	g	NOUN
aiua-1760	31	12	tru	tru	PROPN
aiua-1760	31	13	-	-	PUNCT
aiua-1760	31	14	cut	cut	NOUN
aiua-1760	31	15	needle	needle	NOUN
aiua-1760	31	16	guided	guide	VERB
aiua-1760	31	17	by	by	ADP
aiua-1760	31	18	a	a	DET
aiua-1760	31	19	5	5	NUM
aiua-1760	31	20	-	-	SYM
aiua-1760	31	21	6.5	6.5	NUM
aiua-1760	31	22	mhz	mhz	NOUN
aiua-1760	31	23	biplanar	biplanar	NOUN
aiua-1760	31	24	transrectal	transrectal	ADJ
aiua-1760	31	25	probe	probe	NOUN
aiua-1760	31	26	(	(	PUNCT
aiua-1760	31	27	ge	ge	PROPN
aiua-1760	31	28	logiq	logiq	VERB
aiua-1760	31	29	500	500	NUM
aiua-1760	31	30	pro	pro	NOUN
aiua-1760	31	31	)	)	PUNCT
aiua-1760	31	32	.	.	PUNCT
aiua-1760	32	1	in	in	ADP
aiua-1760	32	2	case	case	NOUN
aiua-1760	32	3	of	of	ADP
aiua-1760	32	4	primary	primary	ADJ
aiua-1760	32	5	biopsy	biopsy	NOUN
aiua-1760	32	6	or	or	CCONJ
aiua-1760	32	7	repeat	repeat	NOUN
aiua-1760	32	8	saturation	saturation	NOUN
aiua-1760	32	9	biopsy	biopsy	NOUN
aiua-1760	32	10	(	(	PUNCT
aiua-1760	32	11	spbx	spbx	PROPN
aiua-1760	32	12	)	)	PUNCT
aiua-1760	32	13	a	a	DET
aiua-1760	32	14	median	median	NOUN
aiua-1760	32	15	of	of	ADP
aiua-1760	32	16	18	18	NUM
aiua-1760	32	17	(	(	PUNCT
aiua-1760	32	18	range	range	NOUN
aiua-1760	32	19	16	16	NUM
aiua-1760	32	20	-	-	SYM
aiua-1760	32	21	21	21	NUM
aiua-1760	32	22	)	)	PUNCT
aiua-1760	32	23	and	and	CCONJ
aiua-1760	32	24	28	28	NUM
aiua-1760	32	25	cores	core	NOUN
aiua-1760	32	26	(	(	PUNCT
aiua-1760	32	27	range	range	NOUN
aiua-1760	32	28	26	26	NUM
aiua-1760	32	29	-	-	SYM
aiua-1760	32	30	35	35	NUM
aiua-1760	32	31	)	)	PUNCT
aiua-1760	32	32	were	be	AUX
aiua-1760	32	33	taken	take	VERB
aiua-1760	32	34	,	,	PUNCT
aiua-1760	32	35	respectively	respectively	ADV
aiua-1760	32	36	.	.	PUNCT
aiua-1760	33	1	the	the	DET
aiua-1760	33	2	biopsy	biopsy	NOUN
aiua-1760	33	3	protocol	protocol	PROPN
aiua-1760	33	4	included	include	VERB
aiua-1760	33	5	a	a	DET
aiua-1760	33	6	median	median	NOUN
aiua-1760	33	7	of	of	ADP
aiua-1760	33	8	9	9	NUM
aiua-1760	33	9	-	-	SYM
aiua-1760	33	10	12	12	NUM
aiua-1760	33	11	cores	core	NOUN
aiua-1760	33	12	in	in	ADP
aiua-1760	33	13	the	the	DET
aiua-1760	33	14	posterior	posterior	ADJ
aiua-1760	33	15	zone	zone	NOUN
aiua-1760	33	16	of	of	ADP
aiua-1760	33	17	each	each	DET
aiua-1760	33	18	lobe	lobe	NOUN
aiua-1760	33	19	(	(	PUNCT
aiua-1760	33	20	apex	apex	NOUN
aiua-1760	33	21	,	,	PUNCT
aiua-1760	33	22	med	med	ADJ
aiua-1760	33	23	and	and	CCONJ
aiua-1760	33	24	base	base	NOUN
aiua-1760	33	25	)	)	PUNCT
aiua-1760	33	26	plus	plus	CCONJ
aiua-1760	33	27	2	2	NUM
aiua-1760	33	28	-	-	SYM
aiua-1760	33	29	4	4	NUM
aiua-1760	33	30	cores	core	NOUN
aiua-1760	33	31	on	on	ADP
aiua-1760	33	32	the	the	DET
aiua-1760	33	33	transition	transition	NOUN
aiua-1760	33	34	zone	zone	NOUN
aiua-1760	33	35	in	in	ADP
aiua-1760	33	36	case	case	NOUN
aiua-1760	33	37	of	of	ADP
aiua-1760	33	38	spbx	spbx	NOUN
aiua-1760	33	39	(	(	PUNCT
aiua-1760	33	40	11	11	NUM
aiua-1760	33	41	)	)	PUNCT
aiua-1760	33	42	.	.	PUNCT
aiua-1760	34	1	the	the	DET
aiua-1760	34	2	procedure	procedure	NOUN
aiua-1760	34	3	was	be	AUX
aiua-1760	34	4	performed	perform	VERB
aiua-1760	34	5	under	under	ADP
aiua-1760	34	6	sedation	sedation	NOUN
aiua-1760	34	7	and	and	CCONJ
aiua-1760	34	8	antibiotic	antibiotic	ADJ
aiua-1760	34	9	prophylaxis	prophylaxis	NOUN
aiua-1760	34	10	.	.	PUNCT
aiua-1760	35	1	all	all	DET
aiua-1760	35	2	patients	patient	NOUN
aiua-1760	35	3	had	have	VERB
aiua-1760	35	4	negative	negative	ADJ
aiua-1760	35	5	dre	dre	NOUN
aiua-1760	35	6	and	and	CCONJ
aiua-1760	35	7	no	no	DET
aiua-1760	35	8	-	-	PUNCT
aiua-1760	35	9	one	one	NOUN
aiua-1760	35	10	was	be	AUX
aiua-1760	35	11	symptomatic	symptomatic	ADJ
aiua-1760	35	12	for	for	ADP
aiua-1760	35	13	acute	acute	ADJ
aiua-1760	35	14	prostatitis	prostatitis	NOUN
aiua-1760	35	15	.	.	PUNCT
aiua-1760	36	1	patients	patient	NOUN
aiua-1760	36	2	with	with	ADP
aiua-1760	36	3	previous	previous	ADJ
aiua-1760	36	4	hgpin	hgpin	NOUN
aiua-1760	36	5	or	or	CCONJ
aiua-1760	36	6	asap	asap	NOUN
aiua-1760	36	7	were	be	AUX
aiua-1760	36	8	not	not	PART
aiua-1760	36	9	included	include	VERB
aiua-1760	36	10	;	;	PUNCT
aiua-1760	36	11	moreover	moreover	ADV
aiua-1760	36	12	,	,	PUNCT
aiua-1760	36	13	all	all	DET
aiua-1760	36	14	patients	patient	NOUN
aiua-1760	36	15	signed	sign	VERB
aiua-1760	36	16	an	an	DET
aiua-1760	36	17	informed	informed	ADJ
aiua-1760	36	18	consent	consent	NOUN
aiua-1760	36	19	form	form	NOUN
aiua-1760	36	20	.	.	PUNCT
aiua-1760	37	1	clinical	clinical	ADJ
aiua-1760	37	2	parameters	parameter	NOUN
aiua-1760	37	3	of	of	ADP
aiua-1760	37	4	the	the	DET
aiua-1760	37	5	patients	patient	NOUN
aiua-1760	37	6	enrolled	enrol	VERB
aiua-1760	37	7	in	in	ADP
aiua-1760	37	8	the	the	DET
aiua-1760	37	9	protocol	protocol	NOUN
aiua-1760	37	10	are	be	AUX
aiua-1760	37	11	listed	list	VERB
aiua-1760	37	12	in	in	ADP
aiua-1760	37	13	table	table	NOUN
aiua-1760	37	14	1	1	NUM
aiua-1760	37	15	;	;	PUNCT
aiua-1760	37	16	37	37	NUM
aiua-1760	37	17	(	(	PUNCT
aiua-1760	37	18	52.8	52.8	NUM
aiua-1760	37	19	%	%	NOUN
aiua-1760	37	20	)	)	PUNCT
aiua-1760	37	21	,	,	PUNCT
aiua-1760	37	22	18	18	NUM
aiua-1760	37	23	(	(	PUNCT
aiua-1760	37	24	25.7	25.7	NUM
aiua-1760	37	25	%	%	NOUN
aiua-1760	37	26	)	)	PUNCT
aiua-1760	37	27	and	and	CCONJ
aiua-1760	37	28	15	15	NUM
aiua-1760	37	29	(	(	PUNCT
aiua-1760	37	30	22.5	22.5	NUM
aiua-1760	37	31	%	%	NOUN
aiua-1760	37	32	)	)	PUNCT
aiua-1760	37	33	men	man	NOUN
aiua-1760	37	34	previously	previously	ADV
aiua-1760	37	35	underwent	undergo	VERB
aiua-1760	37	36	one	one	NUM
aiua-1760	37	37	,	,	PUNCT
aiua-1760	37	38	two	two	NUM
aiua-1760	37	39	and	and	CCONJ
aiua-1760	37	40	three	three	NUM
aiua-1760	37	41	negative	negative	ADJ
aiua-1760	37	42	biopsies	biopsy	NOUN
aiua-1760	37	43	,	,	PUNCT
aiua-1760	37	44	respectively	respectively	ADV
aiua-1760	37	45	.	.	PUNCT
aiua-1760	38	1	fifty	fifty	NUM
aiua-1760	38	2	-	-	PUNCT
aiua-1760	38	3	eight	eight	NUM
aiua-1760	38	4	(	(	PUNCT
aiua-1760	38	5	64.5	64.5	NUM
aiua-1760	38	6	%	%	NOUN
aiua-1760	38	7	)	)	PUNCT
aiua-1760	39	1	patients	patient	NOUN
aiua-1760	39	2	assumed	assume	VERB
aiua-1760	39	3	alpha	alpha	NOUN
aiua-1760	39	4	-	-	PUNCT
aiua-1760	39	5	blockers	blocker	NOUN
aiua-1760	39	6	;	;	PUNCT
aiua-1760	39	7	none	none	NOUN
aiua-1760	39	8	were	be	AUX
aiua-1760	39	9	currently	currently	ADV
aiua-1760	39	10	treated	treat	VERB
aiua-1760	39	11	with	with	ADP
aiua-1760	39	12	nsaids	nsaid	NOUN
aiua-1760	39	13	,	,	PUNCT
aiua-1760	39	14	aspirin	aspirin	NOUN
aiua-1760	39	15	,	,	PUNCT
aiua-1760	39	16	thiazide	thiazide	ADV
aiua-1760	39	17	diuretic	diuretic	NOUN
aiua-1760	39	18	,	,	PUNCT
aiua-1760	39	19	statins	statin	NOUN
aiua-1760	39	20	,	,	PUNCT
aiua-1760	39	21	and	and	CCONJ
aiua-1760	39	22	5	5	NUM
aiua-1760	39	23	-	-	PUNCT
aiua-1760	39	24	alfa	alfa	NOUN
aiua-1760	39	25	-	-	PUNCT
aiua-1760	39	26	reductase	reductase	NOUN
aiua-1760	39	27	inhibitors	inhibitor	NOUN
aiua-1760	39	28	.	.	PUNCT
aiua-1760	40	1	at	at	ADP
aiua-1760	40	2	the	the	DET
aiua-1760	40	3	end	end	NOUN
aiua-1760	40	4	of	of	ADP
aiua-1760	40	5	the	the	DET
aiua-1760	40	6	3months	3months	NUM
aiua-1760	40	7	course	course	NOUN
aiua-1760	40	8	of	of	ADP
aiua-1760	40	9	therapy	therapy	NOUN
aiua-1760	40	10	and	and	CCONJ
aiua-1760	40	11	after	after	ADP
aiua-1760	40	12	additional	additional	ADJ
aiua-1760	40	13	3	3	NUM
aiua-1760	40	14	months	month	NOUN
aiua-1760	40	15	of	of	ADP
aiua-1760	40	16	wash	wash	NOUN
aiua-1760	40	17	-	-	PUNCT
aiua-1760	40	18	out	out	NOUN
aiua-1760	40	19	,	,	PUNCT
aiua-1760	40	20	all	all	DET
aiua-1760	40	21	patients	patient	NOUN
aiua-1760	40	22	were	be	AUX
aiua-1760	40	23	revaluated	revaluate	VERB
aiua-1760	40	24	with	with	ADP
aiua-1760	40	25	dre	dre	PROPN
aiua-1760	40	26	,	,	PUNCT
aiua-1760	40	27	total	total	ADJ
aiua-1760	40	28	psa	psa	NOUN
aiua-1760	40	29	,	,	PUNCT
aiua-1760	40	30	psa	psa	VERB
aiua-1760	40	31	f	f	PROPN
aiua-1760	40	32	/	/	SYM
aiua-1760	40	33	t	t	PROPN
aiua-1760	40	34	and	and	CCONJ
aiua-1760	40	35	routine	routine	ADJ
aiua-1760	40	36	blood	blood	NOUN
aiua-1760	40	37	test	test	NOUN
aiua-1760	40	38	for	for	ADP
aiua-1760	40	39	liver	liver	NOUN
aiua-1760	40	40	and	and	CCONJ
aiua-1760	40	41	kidney	kidney	NOUN
aiua-1760	40	42	function	function	NOUN
aiua-1760	40	43	.	.	PUNCT
aiua-1760	41	1	international	international	ADJ
aiua-1760	41	2	prostate	prostate	NOUN
aiua-1760	41	3	symptoms	symptom	NOUN
aiua-1760	41	4	score	score	VERB
aiua-1760	41	5	(	(	PUNCT
aiua-1760	41	6	ipss	ipss	PROPN
aiua-1760	41	7	)	)	PUNCT
aiua-1760	41	8	and	and	CCONJ
aiua-1760	41	9	qmax	qmax	NOUN
aiua-1760	41	10	before	before	ADP
aiua-1760	41	11	and	and	CCONJ
aiua-1760	41	12	after	after	ADP
aiua-1760	41	13	anti	anti	ADJ
aiua-1760	41	14	-	-	ADJ
aiua-1760	41	15	inflammatory	inflammatory	ADJ
aiua-1760	41	16	therapy	therapy	NOUN
aiua-1760	41	17	were	be	AUX
aiua-1760	41	18	recorded	record	VERB
aiua-1760	41	19	.	.	PUNCT
aiua-1760	42	1	the	the	DET
aiua-1760	42	2	patients	patient	NOUN
aiua-1760	42	3	with	with	ADP
aiua-1760	42	4	persistent	persistent	ADJ
aiua-1760	42	5	suspicious	suspicious	NOUN
aiua-1760	42	6	for	for	ADP
aiua-1760	42	7	pca	pca	NOUN
aiua-1760	42	8	underwent	underwent	NOUN
aiua-1760	42	9	spbx	spbx	NOUN
aiua-1760	42	10	.	.	PUNCT
aiua-1760	43	1	the	the	DET
aiua-1760	43	2	repeat	repeat	NOUN
aiua-1760	43	3	spbx	spbx	PROPN
aiua-1760	43	4	rate	rate	NOUN
aiua-1760	43	5	after	after	ADP
aiua-1760	43	6	anti	anti	ADJ
aiua-1760	43	7	-	-	ADJ
aiua-1760	43	8	inflammatory	inflammatory	ADJ
aiua-1760	43	9	therapy	therapy	NOUN
aiua-1760	43	10	and	and	CCONJ
aiua-1760	43	11	detection	detection	NOUN
aiua-1760	43	12	rate	rate	NOUN
aiua-1760	43	13	for	for	ADP
aiua-1760	43	14	pca	pca	PROPN
aiua-1760	43	15	were	be	AUX
aiua-1760	43	16	compared	compare	VERB
aiua-1760	43	17	with	with	ADP
aiua-1760	43	18	those	those	DET
aiua-1760	43	19	previ70	previ70	NOUN
aiua-1760	43	20	patients	patient	NOUN
aiua-1760	43	21	baseline	baseline	VERB
aiua-1760	43	22	after	after	ADP
aiua-1760	43	23	therapy	therapy	NOUN
aiua-1760	43	24	%	%	NOUN
aiua-1760	43	25	of	of	ADP
aiua-1760	43	26	reduction	reduction	NOUN
aiua-1760	43	27	p	p	NOUN
aiua-1760	43	28	value	value	NOUN
aiua-1760	43	29	median	median	NOUN
aiua-1760	43	30	psa	psa	NOUN
aiua-1760	43	31	(	(	PUNCT
aiua-1760	43	32	ng	ng	PROPN
aiua-1760	43	33	/	/	SYM
aiua-1760	43	34	ml	ml	PROPN
aiua-1760	43	35	)	)	PUNCT
aiua-1760	43	36	8.8	8.8	NUM
aiua-1760	43	37	(	(	PUNCT
aiua-1760	43	38	range	range	NOUN
aiua-1760	43	39	:	:	PUNCT
aiua-1760	43	40	4.6	4.6	NUM
aiua-1760	43	41	-	-	SYM
aiua-1760	43	42	28	28	NUM
aiua-1760	43	43	)	)	PUNCT
aiua-1760	43	44	7	7	NUM
aiua-1760	43	45	(	(	PUNCT
aiua-1760	43	46	range	range	NOUN
aiua-1760	43	47	:	:	PUNCT
aiua-1760	43	48	2.9	2.9	NUM
aiua-1760	43	49	-	-	SYM
aiua-1760	43	50	23	23	NUM
aiua-1760	43	51	)	)	PUNCT
aiua-1760	43	52	20.5	20.5	NUM
aiua-1760	43	53	<	<	SYM
aiua-1760	43	54	0.05	0.05	NUM
aiua-1760	43	55	decreased	decrease	VERB
aiua-1760	43	56	psa	psa	NOUN
aiua-1760	43	57	levels	level	NOUN
aiua-1760	43	58	54	54	NUM
aiua-1760	43	59	77.2	77.2	NUM
aiua-1760	43	60	<	<	X
aiua-1760	43	61	0.05	0.05	NUM
aiua-1760	43	62	psa	psa	NOUN
aiua-1760	43	63	>	>	X
aiua-1760	43	64	10	10	NUM
aiua-1760	43	65	14	14	NUM
aiua-1760	43	66	10	10	NUM
aiua-1760	43	67	28.5	28.5	NUM
aiua-1760	43	68	<	<	X
aiua-1760	43	69	0.05	0.05	NUM
aiua-1760	43	70	psa	psa	NOUN
aiua-1760	43	71	4	4	NUM
aiua-1760	43	72	-	-	SYM
aiua-1760	43	73	10	10	NUM
aiua-1760	43	74	54	54	NUM
aiua-1760	43	75	40	40	NUM
aiua-1760	43	76	26.0	26.0	NUM
aiua-1760	43	77	<	<	X
aiua-1760	43	78	0.05	0.05	NUM
aiua-1760	43	79	psa	psa	NOUN
aiua-1760	43	80	<	<	X
aiua-1760	43	81	4	4	NUM
aiua-1760	43	82	0	0	NUM
aiua-1760	43	83	20	20	NUM
aiua-1760	43	84	28.5	28.5	NUM
aiua-1760	43	85	<	<	X
aiua-1760	43	86	0.05	0.05	NUM
aiua-1760	43	87	ipss	ipss	PROPN
aiua-1760	43	88	(	(	PUNCT
aiua-1760	43	89	range	range	NOUN
aiua-1760	43	90	)	)	PUNCT
aiua-1760	43	91	13	13	NUM
aiua-1760	43	92	(	(	PUNCT
aiua-1760	43	93	4	4	NUM
aiua-1760	43	94	-	-	SYM
aiua-1760	43	95	26	26	NUM
aiua-1760	43	96	)	)	PUNCT
aiua-1760	43	97	12	12	NUM
aiua-1760	43	98	(	(	PUNCT
aiua-1760	43	99	5	5	NUM
aiua-1760	43	100	-	-	SYM
aiua-1760	43	101	24	24	NUM
aiua-1760	43	102	)	)	PUNCT
aiua-1760	43	103	>	>	X
aiua-1760	43	104	0.05	0.05	NUM
aiua-1760	43	105	low	low	ADJ
aiua-1760	43	106	(	(	PUNCT
aiua-1760	43	107	0	0	NUM
aiua-1760	43	108	-	-	SYM
aiua-1760	43	109	7	7	NUM
aiua-1760	43	110	)	)	PUNCT
aiua-1760	43	111	36	36	NUM
aiua-1760	43	112	38	38	NUM
aiua-1760	43	113	>	>	SYM
aiua-1760	43	114	0.05	0.05	NUM
aiua-1760	43	115	intermediate	intermediate	ADJ
aiua-1760	43	116	(	(	PUNCT
aiua-1760	43	117	8	8	NUM
aiua-1760	43	118	-	-	SYM
aiua-1760	43	119	19	19	NUM
aiua-1760	43	120	)	)	PUNCT
aiua-1760	43	121	25	25	NUM
aiua-1760	43	122	23	23	NUM
aiua-1760	43	123	>	>	SYM
aiua-1760	43	124	0.05	0.05	NUM
aiua-1760	43	125	severe	severe	ADJ
aiua-1760	43	126	(	(	PUNCT
aiua-1760	43	127	20	20	NUM
aiua-1760	43	128	-	-	SYM
aiua-1760	43	129	37	37	NUM
aiua-1760	43	130	)	)	PUNCT
aiua-1760	43	131	9	9	NUM
aiua-1760	43	132	9	9	NUM
aiua-1760	43	133	>	>	SYM
aiua-1760	43	134	0.05	0.05	NUM
aiua-1760	43	135	qmax	qmax	NOUN
aiua-1760	43	136	11	11	NUM
aiua-1760	43	137	ml	ml	PROPN
aiua-1760	43	138	/	/	SYM
aiua-1760	43	139	sec	sec	PROPN
aiua-1760	43	140	12	12	NUM
aiua-1760	43	141	ml	ml	NOUN
aiua-1760	43	142	/	/	SYM
aiua-1760	43	143	sec	sec	PROPN
aiua-1760	43	144	>	>	SYM
aiua-1760	43	145	0.05	0.05	NUM
aiua-1760	43	146	urine	urine	NOUN
aiua-1760	43	147	test	test	NOUN
aiua-1760	43	148	negative	negative	ADJ
aiua-1760	43	149	negative	negative	ADJ
aiua-1760	43	150	blood	blood	NOUN
aiua-1760	43	151	test	test	NOUN
aiua-1760	43	152	normal	normal	ADJ
aiua-1760	43	153	normal	normal	ADJ
aiua-1760	43	154	table	table	NOUN
aiua-1760	43	155	1	1	NUM
aiua-1760	43	156	.	.	PUNCT
aiua-1760	43	157	clinical	clinical	ADJ
aiua-1760	43	158	parameters	parameter	NOUN
aiua-1760	43	159	at	at	ADP
aiua-1760	43	160	baseline	baseline	NOUN
aiua-1760	43	161	and	and	CCONJ
aiua-1760	43	162	6	6	NUM
aiua-1760	43	163	months	month	NOUN
aiua-1760	43	164	after	after	ADP
aiua-1760	43	165	anti	anti	ADJ
aiua-1760	43	166	-	-	ADJ
aiua-1760	43	167	inflammatory	inflammatory	ADJ
aiua-1760	43	168	therapy	therapy	NOUN
aiua-1760	43	169	.	.	PUNCT
aiua-1760	44	1	candiano_stesura	candiano_stesura	ADJ
aiua-1760	44	2	seveso	seveso	VERB
aiua-1760	44	3	24/06/13	24/06/13	PROPN
aiua-1760	44	4	10:59	10:59	NUM
aiua-1760	44	5	pagina	pagina	NOUN
aiua-1760	44	6	66	66	NUM
aiua-1760	44	7	67archivio	67archivio	NUM
aiua-1760	44	8	italiano	italiano	PROPN
aiua-1760	44	9	di	di	X
aiua-1760	44	10	urologia	urologia	PROPN
aiua-1760	44	11	e	e	PROPN
aiua-1760	44	12	andrologia	andrologia	NOUN
aiua-1760	44	13	2013	2013	NUM
aiua-1760	44	14	;	;	PUNCT
aiua-1760	44	15	85	85	NUM
aiua-1760	44	16	,	,	PUNCT
aiua-1760	44	17	2	2	NUM
aiua-1760	44	18	does	do	AUX
aiua-1760	44	19	prolonged	prolong	VERB
aiua-1760	44	20	anti	anti	ADJ
aiua-1760	44	21	-	-	ADJ
aiua-1760	44	22	inflammatory	inflammatory	ADJ
aiua-1760	44	23	therapy	therapy	NOUN
aiua-1760	44	24	reduce	reduce	VERB
aiua-1760	44	25	number	number	NOUN
aiua-1760	44	26	of	of	ADP
aiua-1760	44	27	unnecessary	unnecessary	ADJ
aiua-1760	44	28	repeat	repeat	NOUN
aiua-1760	44	29	saturation	saturation	NOUN
aiua-1760	44	30	prostate	prostate	NOUN
aiua-1760	44	31	biopsy	biopsy	NOUN
aiua-1760	44	32	?	?	PUNCT
aiua-1760	45	1	anti	anti	ADJ
aiua-1760	45	2	-	-	ADJ
aiua-1760	45	3	inflammatory	inflammatory	ADJ
aiua-1760	45	4	therapy	therapy	NOUN
aiua-1760	45	5	reduced	reduce	VERB
aiua-1760	45	6	psa	psa	NOUN
aiua-1760	45	7	levels	level	NOUN
aiua-1760	45	8	in	in	ADP
aiua-1760	45	9	selected	select	VERB
aiua-1760	45	10	patients	patient	NOUN
aiua-1760	45	11	(	(	PUNCT
aiua-1760	45	12	negative	negative	ADJ
aiua-1760	45	13	prostate	prostate	NOUN
aiua-1760	45	14	biopsy	biopsy	NOUN
aiua-1760	45	15	and	and	CCONJ
aiua-1760	45	16	persistent	persistent	ADJ
aiua-1760	45	17	elevated	elevated	ADJ
aiua-1760	45	18	psa	psa	NOUN
aiua-1760	45	19	values	value	NOUN
aiua-1760	45	20	)	)	PUNCT
aiua-1760	45	21	decreasing	decrease	VERB
aiua-1760	45	22	the	the	DET
aiua-1760	45	23	indication	indication	NOUN
aiua-1760	45	24	to	to	PART
aiua-1760	45	25	perform	perform	VERB
aiua-1760	45	26	repeat	repeat	NOUN
aiua-1760	45	27	spbx	spbx	NOUN
aiua-1760	45	28	(	(	PUNCT
aiua-1760	45	29	about	about	ADV
aiua-1760	45	30	30	30	NUM
aiua-1760	45	31	%	%	NOUN
aiua-1760	45	32	of	of	ADP
aiua-1760	45	33	the	the	DET
aiua-1760	45	34	cases	case	NOUN
aiua-1760	45	35	)	)	PUNCT
aiua-1760	45	36	.	.	PUNCT
aiua-1760	46	1	references	reference	NOUN
aiua-1760	46	2	1	1	NUM
aiua-1760	46	3	.	.	PUNCT
aiua-1760	47	1	nixon	nixon	PROPN
aiua-1760	47	2	rg	rg	PROPN
aiua-1760	47	3	,	,	PUNCT
aiua-1760	47	4	lilly	lilly	PROPN
aiua-1760	47	5	jd	jd	PROPN
aiua-1760	47	6	,	,	PUNCT
aiua-1760	47	7	liedtke	liedtke	PROPN
aiua-1760	47	8	rj	rj	PROPN
aiua-1760	47	9	,	,	PUNCT
aiua-1760	47	10	batjer	batjer	PROPN
aiua-1760	47	11	jd	jd	PROPN
aiua-1760	47	12	.	.	PROPN
aiua-1760	47	13	variation	variation	NOUN
aiua-1760	47	14	of	of	ADP
aiua-1760	47	15	free	free	ADJ
aiua-1760	47	16	and	and	CCONJ
aiua-1760	47	17	total	total	ADJ
aiua-1760	47	18	psa	psa	NOUN
aiua-1760	47	19	levels	level	NOUN
aiua-1760	47	20	:	:	PUNCT
aiua-1760	47	21	the	the	DET
aiua-1760	47	22	effect	effect	NOUN
aiua-1760	47	23	on	on	ADP
aiua-1760	47	24	the	the	DET
aiua-1760	47	25	percent	percent	NOUN
aiua-1760	47	26	free	free	ADJ
aiua-1760	47	27	/	/	SYM
aiua-1760	47	28	total	total	ADJ
aiua-1760	47	29	prostate	prostate	NOUN
aiua-1760	47	30	antigen	antigen	ADV
aiua-1760	47	31	.	.	PUNCT
aiua-1760	48	1	arch	arch	ADJ
aiua-1760	48	2	pathol	pathol	NOUN
aiua-1760	48	3	lab	lab	NOUN
aiua-1760	48	4	med	me	VERB
aiua-1760	48	5	.	.	PUNCT
aiua-1760	48	6	1997	1997	NUM
aiua-1760	48	7	;	;	PUNCT
aiua-1760	48	8	121:385	121:385	PROPN
aiua-1760	48	9	-	-	SYM
aiua-1760	48	10	91	91	NUM
aiua-1760	48	11	.	.	PUNCT
aiua-1760	49	1	2	2	X
aiua-1760	49	2	.	.	PUNCT
aiua-1760	49	3	yaman	yaman	PROPN
aiua-1760	49	4	o	o	NOUN
aiua-1760	49	5	,	,	PUNCT
aiua-1760	49	6	gogus	gogus	PROPN
aiua-1760	49	7	c	c	NOUN
aiua-1760	49	8	,	,	PUNCT
aiua-1760	49	9	tulunay	tulunay	ADV
aiua-1760	49	10	o	o	NOUN
aiua-1760	49	11	,	,	PUNCT
aiua-1760	49	12	et	et	PROPN
aiua-1760	49	13	al	al	PROPN
aiua-1760	49	14	.	.	PROPN
aiua-1760	49	15	increased	increase	VERB
aiua-1760	49	16	psa	psa	NOUN
aiua-1760	49	17	in	in	ADP
aiua-1760	49	18	subclinical	subclinical	ADJ
aiua-1760	49	19	prostatitis	prostatitis	NOUN
aiua-1760	49	20	:	:	PUNCT
aiua-1760	49	21	the	the	DET
aiua-1760	49	22	role	role	NOUN
aiua-1760	49	23	of	of	ADP
aiua-1760	49	24	aggressiveness	aggressiveness	NOUN
aiua-1760	49	25	and	and	CCONJ
aiua-1760	49	26	extension	extension	NOUN
aiua-1760	49	27	of	of	ADP
aiua-1760	49	28	inflammation	inflammation	NOUN
aiua-1760	49	29	.	.	PUNCT
aiua-1760	50	1	urol	urol	PROPN
aiua-1760	50	2	int	int	PROPN
aiua-1760	50	3	.	.	PUNCT
aiua-1760	51	1	2003	2003	NUM
aiua-1760	51	2	;	;	PUNCT
aiua-1760	51	3	71:160	71:160	NOUN
aiua-1760	51	4	-	-	SYM
aiua-1760	51	5	164	164	NUM
aiua-1760	51	6	.	.	PUNCT
aiua-1760	52	1	3	3	X
aiua-1760	52	2	.	.	X
aiua-1760	52	3	kandirali	kandirali	PROPN
aiua-1760	52	4	e	e	PROPN
aiua-1760	52	5	,	,	PUNCT
aiua-1760	52	6	boran	boran	PROPN
aiua-1760	52	7	c	c	PROPN
aiua-1760	52	8	,	,	PUNCT
aiua-1760	52	9	serin	serin	PROPN
aiua-1760	52	10	e.	e.	PROPN
aiua-1760	52	11	association	association	PROPN
aiua-1760	52	12	of	of	ADP
aiua-1760	52	13	extent	extent	NOUN
aiua-1760	52	14	and	and	CCONJ
aiua-1760	52	15	aggressiveness	aggressiveness	NOUN
aiua-1760	52	16	of	of	ADP
aiua-1760	52	17	inflammation	inflammation	NOUN
aiua-1760	52	18	with	with	ADP
aiua-1760	52	19	serum	serum	NOUN
aiua-1760	52	20	psa	psa	NOUN
aiua-1760	52	21	levels	level	NOUN
aiua-1760	52	22	and	and	CCONJ
aiua-1760	52	23	psa	psa	VERB
aiua-1760	52	24	density	density	NOUN
aiua-1760	52	25	in	in	ADP
aiua-1760	52	26	asymptomatic	asymptomatic	ADJ
aiua-1760	52	27	patients	patient	NOUN
aiua-1760	52	28	.	.	PUNCT
aiua-1760	53	1	urology	urology	NOUN
aiua-1760	53	2	.	.	PUNCT
aiua-1760	54	1	2007	2007	NUM
aiua-1760	54	2	;	;	PUNCT
aiua-1760	54	3	70:743	70:743	NUM
aiua-1760	54	4	-	-	SYM
aiua-1760	54	5	747	747	NUM
aiua-1760	54	6	.	.	NOUN
aiua-1760	55	1	2	2	NUM
aiua-1760	55	2	.	.	X
aiua-1760	55	3	hochreiter	hochreiter	PROPN
aiua-1760	55	4	ww	ww	PROPN
aiua-1760	55	5	.	.	PUNCT
aiua-1760	56	1	the	the	DET
aiua-1760	56	2	issue	issue	NOUN
aiua-1760	56	3	of	of	ADP
aiua-1760	56	4	prostate	prostate	NOUN
aiua-1760	56	5	cancer	cancer	NOUN
aiua-1760	56	6	evaluation	evaluation	NOUN
aiua-1760	56	7	in	in	ADP
aiua-1760	56	8	men	man	NOUN
aiua-1760	56	9	with	with	ADP
aiua-1760	56	10	elevated	elevated	ADJ
aiua-1760	56	11	psa	psa	NOUN
aiua-1760	56	12	and	and	CCONJ
aiua-1760	56	13	chronic	chronic	ADJ
aiua-1760	56	14	prostatitis	prostatitis	NOUN
aiua-1760	56	15	.	.	PUNCT
aiua-1760	57	1	andrologia	andrologia	PROPN
aiua-1760	57	2	.	.	PUNCT
aiua-1760	58	1	2008	2008	NUM
aiua-1760	58	2	;	;	PUNCT
aiua-1760	58	3	40:130	40:130	NUM
aiua-1760	58	4	-	-	SYM
aiua-1760	58	5	133	133	NUM
aiua-1760	58	6	.	.	PUNCT
aiua-1760	59	1	3	3	X
aiua-1760	59	2	.	.	X
aiua-1760	59	3	stopiglia	stopiglia	PROPN
aiua-1760	59	4	rm	rm	PROPN
aiua-1760	59	5	,	,	PUNCT
aiua-1760	59	6	ferreira	ferreira	PROPN
aiua-1760	59	7	u	u	PROPN
aiua-1760	59	8	,	,	PUNCT
aiua-1760	59	9	silva	silva	PROPN
aiua-1760	59	10	mm	mm	PROPN
aiua-1760	59	11	,	,	PUNCT
aiua-1760	59	12	et	et	PROPN
aiua-1760	59	13	al	al	PROPN
aiua-1760	59	14	.	.	PROPN
aiua-1760	60	1	psa	psa	PROPN
aiua-1760	60	2	decrease	decrease	NOUN
aiua-1760	60	3	and	and	CCONJ
aiua-1760	60	4	prostate	prostate	NOUN
aiua-1760	60	5	cancer	cancer	NOUN
aiua-1760	60	6	diagnosis	diagnosis	NOUN
aiua-1760	60	7	:	:	PUNCT
aiua-1760	60	8	antibiotic	antibiotic	ADJ
aiua-1760	60	9	versus	versus	ADP
aiua-1760	60	10	placebo	placebo	NOUN
aiua-1760	60	11	.	.	PUNCT
aiua-1760	61	1	prospective	prospective	ADJ
aiua-1760	61	2	randomized	randomize	VERB
aiua-1760	61	3	clinical	clinical	ADJ
aiua-1760	61	4	trial	trial	NOUN
aiua-1760	61	5	.	.	PUNCT
aiua-1760	62	1	j	j	PROPN
aiua-1760	62	2	urol	urol	PROPN
aiua-1760	62	3	.	.	PUNCT
aiua-1760	63	1	2010	2010	NUM
aiua-1760	63	2	;	;	PUNCT
aiua-1760	63	3	183:940	183:940	NOUN
aiua-1760	63	4	-	-	SYM
aiua-1760	63	5	944	944	NUM
aiua-1760	63	6	.	.	NOUN
aiua-1760	64	1	4	4	X
aiua-1760	64	2	.	.	X
aiua-1760	64	3	magri	magri	VERB
aiua-1760	64	4	v	v	ADP
aiua-1760	64	5	,	,	PUNCT
aiua-1760	64	6	trinchieri	trinchieri	PROPN
aiua-1760	64	7	a	a	X
aiua-1760	64	8	,	,	PUNCT
aiua-1760	64	9	montanari	montanari	PROPN
aiua-1760	64	10	e	e	PROPN
aiua-1760	64	11	,	,	PUNCT
aiua-1760	64	12	et	et	PROPN
aiua-1760	64	13	al	al	PROPN
aiua-1760	64	14	.	.	PUNCT
aiua-1760	65	1	reduction	reduction	NOUN
aiua-1760	65	2	of	of	ADP
aiua-1760	65	3	psa	psa	NOUN
aiua-1760	65	4	values	value	NOUN
aiua-1760	65	5	by	by	ADP
aiua-1760	65	6	combination	combination	NOUN
aiua-1760	65	7	pharmacological	pharmacological	NOUN
aiua-1760	65	8	therapy	therapy	NOUN
aiua-1760	65	9	in	in	ADP
aiua-1760	65	10	patients	patient	NOUN
aiua-1760	65	11	with	with	ADP
aiua-1760	65	12	chronic	chronic	ADJ
aiua-1760	65	13	prostatitis	prostatitis	NOUN
aiua-1760	65	14	:	:	PUNCT
aiua-1760	65	15	implications	implication	NOUN
aiua-1760	65	16	for	for	ADP
aiua-1760	65	17	prostate	prostate	NOUN
aiua-1760	65	18	cancer	cancer	NOUN
aiua-1760	65	19	detection	detection	NOUN
aiua-1760	65	20	.	.	PUNCT
aiua-1760	66	1	arch	arch	VERB
aiua-1760	66	2	it	it	PRON
aiua-1760	66	3	urol	urol	ADP
aiua-1760	66	4	androl	androl	PROPN
aiua-1760	66	5	.	.	PROPN
aiua-1760	66	6	2007	2007	NUM
aiua-1760	66	7	;	;	PUNCT
aiua-1760	66	8	79:84	79:84	NUM
aiua-1760	66	9	-	-	SYM
aiua-1760	66	10	92	92	NUM
aiua-1760	66	11	.	.	PUNCT
aiua-1760	67	1	5	5	X
aiua-1760	67	2	.	.	X
aiua-1760	67	3	serretta	serretta	PROPN
aiua-1760	67	4	v	v	PROPN
aiua-1760	67	5	,	,	PUNCT
aiua-1760	67	6	catanese	catanese	NOUN
aiua-1760	67	7	a	a	PROPN
aiua-1760	67	8	,	,	PUNCT
aiua-1760	67	9	daricello	daricello	VERB
aiua-1760	67	10	g	g	PROPN
aiua-1760	67	11	,	,	PUNCT
aiua-1760	67	12	et	et	PROPN
aiua-1760	67	13	al	al	PROPN
aiua-1760	67	14	.	.	PROPN
aiua-1760	67	15	psa	psa	PROPN
aiua-1760	67	16	reduction	reduction	NOUN
aiua-1760	67	17	(	(	PUNCT
aiua-1760	67	18	after	after	ADP
aiua-1760	67	19	antibiotics	antibiotic	NOUN
aiua-1760	67	20	)	)	PUNCT
aiua-1760	67	21	permits	permit	VERB
aiua-1760	67	22	to	to	PART
aiua-1760	67	23	avoid	avoid	VERB
aiua-1760	67	24	or	or	CCONJ
aiua-1760	67	25	postpone	postpone	VERB
aiua-1760	67	26	prostate	prostate	NOUN
aiua-1760	67	27	biopsy	biopsy	NOUN
aiua-1760	67	28	in	in	ADP
aiua-1760	67	29	selected	select	VERB
aiua-1760	67	30	patients	patient	NOUN
aiua-1760	67	31	.	.	PUNCT
aiua-1760	68	1	prostate	prostate	NOUN
aiua-1760	68	2	cancer	cancer	NOUN
aiua-1760	68	3	prostatic	prostatic	ADJ
aiua-1760	68	4	diseases	disease	NOUN
aiua-1760	68	5	.	.	PUNCT
aiua-1760	69	1	2008	2008	NUM
aiua-1760	69	2	;	;	PUNCT
aiua-1760	69	3	11:148	11:148	NUM
aiua-1760	69	4	-	-	SYM
aiua-1760	69	5	152	152	NUM
aiua-1760	69	6	.	.	PUNCT
aiua-1760	70	1	6	6	NUM
aiua-1760	70	2	.	.	X
aiua-1760	70	3	schaeffer	schaeffer	PROPN
aiua-1760	70	4	aj	aj	PROPN
aiua-1760	70	5	,	,	PUNCT
aiua-1760	70	6	wu	wu	PROPN
aiua-1760	70	7	sc	sc	PROPN
aiua-1760	70	8	,	,	PUNCT
aiua-1760	70	9	tennenberg	tennenberg	PROPN
aiua-1760	70	10	am	be	AUX
aiua-1760	70	11	,	,	PUNCT
aiua-1760	70	12	kahn	kahn	PROPN
aiua-1760	70	13	jb	jb	PROPN
aiua-1760	70	14	.	.	PUNCT
aiua-1760	71	1	treatment	treatment	NOUN
aiua-1760	71	2	of	of	ADP
aiua-1760	71	3	chronic	chronic	ADJ
aiua-1760	71	4	bacterial	bacterial	ADJ
aiua-1760	71	5	prostatitis	prostatitis	NOUN
aiua-1760	71	6	with	with	ADP
aiua-1760	71	7	levofloxacin	levofloxacin	PROPN
aiua-1760	71	8	and	and	CCONJ
aiua-1760	71	9	ciprofloxacin	ciprofloxacin	NOUN
aiua-1760	71	10	lowers	lower	VERB
aiua-1760	71	11	serum	serum	NOUN
aiua-1760	71	12	psa	psa	PROPN
aiua-1760	71	13	.	.	PUNCT
aiua-1760	72	1	j	j	PROPN
aiua-1760	72	2	urol	urol	PROPN
aiua-1760	72	3	.	.	PUNCT
aiua-1760	73	1	2005	2005	NUM
aiua-1760	73	2	;	;	PUNCT
aiua-1760	74	1	174:161	174:161	NUM
aiua-1760	74	2	-	-	SYM
aiua-1760	74	3	164	164	NUM
aiua-1760	74	4	.	.	PUNCT
aiua-1760	75	1	7	7	X
aiua-1760	75	2	.	.	X
aiua-1760	75	3	terrone	terrone	NOUN
aiua-1760	75	4	c	c	NOUN
aiua-1760	75	5	,	,	PUNCT
aiua-1760	75	6	poggio	poggio	PROPN
aiua-1760	75	7	m	m	PROPN
aiua-1760	75	8	,	,	PUNCT
aiua-1760	75	9	bollito	bollito	PROPN
aiua-1760	75	10	e	e	NOUN
aiua-1760	75	11	,	,	PUNCT
aiua-1760	75	12	et	et	PROPN
aiua-1760	75	13	al	al	PROPN
aiua-1760	75	14	.	.	PUNCT
aiua-1760	76	1	asymptomatic	asymptomatic	ADJ
aiua-1760	76	2	prostatitis	prostatitis	NOUN
aiua-1760	76	3	:	:	PUNCT
aiua-1760	76	4	a	a	DET
aiua-1760	76	5	frequent	frequent	ADJ
aiua-1760	76	6	cause	cause	NOUN
aiua-1760	76	7	of	of	ADP
aiua-1760	76	8	raising	raise	VERB
aiua-1760	76	9	psa	psa	NOUN
aiua-1760	76	10	.	.	PUNCT
aiua-1760	76	11	rec	rec	PROPN
aiua-1760	76	12	prog	prog	PROPN
aiua-1760	76	13	med	med	PROPN
aiua-1760	76	14	.	.	PUNCT
aiua-1760	76	15	2005	2005	NUM
aiua-1760	76	16	;	;	PUNCT
aiua-1760	76	17	96:365	96:365	NUM
aiua-1760	76	18	-	-	SYM
aiua-1760	76	19	369	369	NUM
aiua-1760	76	20	.	.	PUNCT
aiua-1760	77	1	8	8	NUM
aiua-1760	77	2	.	.	X
aiua-1760	78	1	erol	erol	PROPN
aiua-1760	78	2	h	h	PROPN
aiua-1760	78	3	,	,	PUNCT
aiua-1760	78	4	beder	beder	NOUN
aiua-1760	78	5	n	n	CCONJ
aiua-1760	78	6	,	,	PUNCT
aiua-1760	78	7	caliskan	caliskan	PROPN
aiua-1760	78	8	t	t	PROPN
aiua-1760	78	9	,	,	PUNCT
aiua-1760	78	10	et	et	PROPN
aiua-1760	78	11	al	al	PROPN
aiua-1760	78	12	.	.	PUNCT
aiua-1760	79	1	can	can	AUX
aiua-1760	79	2	the	the	DET
aiua-1760	79	3	effect	effect	NOUN
aiua-1760	79	4	of	of	ADP
aiua-1760	79	5	antibiotic	antibiotic	ADJ
aiua-1760	79	6	therapy	therapy	NOUN
aiua-1760	79	7	and	and	CCONJ
aiua-1760	79	8	anti	anti	ADJ
aiua-1760	79	9	-	-	ADJ
aiua-1760	79	10	inflammatory	inflammatory	ADJ
aiua-1760	79	11	therapy	therapy	NOUN
aiua-1760	79	12	on	on	ADP
aiua-1760	79	13	serum	serum	NOUN
aiua-1760	79	14	psa	psa	NOUN
aiua-1760	79	15	levels	level	NOUN
aiua-1760	79	16	discriminate	discriminate	VERB
aiua-1760	79	17	between	between	ADP
aiua-1760	79	18	benign	benign	ADJ
aiua-1760	79	19	and	and	CCONJ
aiua-1760	79	20	malign	malign	ADJ
aiua-1760	79	21	prostatic	prostatic	ADJ
aiua-1760	79	22	pathologies	pathology	NOUN
aiua-1760	79	23	?	?	PUNCT
aiua-1760	80	1	urol	urol	PROPN
aiua-1760	80	2	int	int	PROPN
aiua-1760	80	3	.	.	PUNCT
aiua-1760	81	1	2006	2006	NUM
aiua-1760	81	2	;	;	PUNCT
aiua-1760	82	1	76:20	76:20	NUM
aiua-1760	82	2	-	-	SYM
aiua-1760	82	3	26	26	NUM
aiua-1760	82	4	.	.	NOUN
aiua-1760	83	1	9	9	NUM
aiua-1760	83	2	.	.	X
aiua-1760	83	3	murad	murad	NOUN
aiua-1760	83	4	as	as	ADP
aiua-1760	83	5	,	,	PUNCT
aiua-1760	83	6	down	down	ADP
aiua-1760	83	7	l	l	NOUN
aiua-1760	83	8	,	,	PUNCT
aiua-1760	83	9	davey	davey	PROPN
aiua-1760	83	10	smith	smith	PROPN
aiua-1760	83	11	g	g	PROPN
aiua-1760	83	12	,	,	PUNCT
aiua-1760	83	13	et	et	PROPN
aiua-1760	83	14	al	al	PROPN
aiua-1760	83	15	.	.	PROPN
aiua-1760	84	1	associations	association	NOUN
aiua-1760	84	2	of	of	ADP
aiua-1760	84	3	aspirin	aspirin	NOUN
aiua-1760	84	4	,	,	PUNCT
aiua-1760	84	5	nonsteroidal	nonsteroidal	NOUN
aiua-1760	84	6	-	-	PUNCT
aiua-1760	84	7	antiflammatory	antiflammatory	NOUN
aiua-1760	84	8	drug	drug	NOUN
aiua-1760	84	9	and	and	CCONJ
aiua-1760	84	10	paracetamol	paracetamol	NOUN
aiua-1760	84	11	use	use	NOUN
aiua-1760	84	12	with	with	ADP
aiua-1760	84	13	psadetected	psadetecte	VERB
aiua-1760	84	14	prostate	prostate	NOUN
aiua-1760	84	15	cancer	cancer	NOUN
aiua-1760	84	16	:	:	PUNCT
aiua-1760	84	17	findings	finding	NOUN
aiua-1760	84	18	from	from	ADP
aiua-1760	84	19	a	a	DET
aiua-1760	84	20	large	large	ADJ
aiua-1760	84	21	,	,	PUNCT
aiua-1760	84	22	population	population	NOUN
aiua-1760	84	23	-	-	PUNCT
aiua-1760	84	24	based	base	VERB
aiua-1760	84	25	,	,	PUNCT
aiua-1760	84	26	casecontrol	casecontrol	NOUN
aiua-1760	84	27	study	study	NOUN
aiua-1760	84	28	(	(	PUNCT
aiua-1760	84	29	the	the	DET
aiua-1760	84	30	protect	protect	NOUN
aiua-1760	84	31	study	study	NOUN
aiua-1760	84	32	)	)	PUNCT
aiua-1760	84	33	.	.	PUNCT
aiua-1760	85	1	int	int	PROPN
aiua-1760	85	2	j	j	PROPN
aiua-1760	85	3	cancer	cancer	NOUN
aiua-1760	85	4	.	.	PUNCT
aiua-1760	86	1	2011	2011	NUM
aiua-1760	86	2	;	;	PUNCT
aiua-1760	86	3	128:1442	128:1442	NUM
aiua-1760	86	4	-	-	SYM
aiua-1760	86	5	48	48	NUM
aiua-1760	86	6	.	.	PUNCT
aiua-1760	87	1	10	10	NUM
aiua-1760	87	2	.	.	PUNCT
aiua-1760	88	1	pepe	pepe	PROPN
aiua-1760	88	2	p	p	PROPN
aiua-1760	88	3	,	,	PUNCT
aiua-1760	88	4	aragona	aragona	PROPN
aiua-1760	88	5	f.	f.	PROPN
aiua-1760	88	6	incidence	incidence	PROPN
aiua-1760	88	7	of	of	ADP
aiua-1760	88	8	insignificant	insignificant	ADJ
aiua-1760	88	9	prostate	prostate	NOUN
aiua-1760	88	10	cancer	cancer	NOUN
aiua-1760	88	11	using	use	VERB
aiua-1760	88	12	free	free	ADJ
aiua-1760	88	13	/	/	SYM
aiua-1760	88	14	total	total	ADJ
aiua-1760	88	15	psa	psa	NOUN
aiua-1760	88	16	:	:	PUNCT
aiua-1760	88	17	results	result	NOUN
aiua-1760	88	18	of	of	ADP
aiua-1760	88	19	a	a	DET
aiua-1760	88	20	case	case	NOUN
aiua-1760	88	21	-	-	PUNCT
aiua-1760	88	22	finding	find	VERB
aiua-1760	88	23	protocol	protocol	NOUN
aiua-1760	88	24	on	on	ADP
aiua-1760	88	25	14,453	14,453	NUM
aiua-1760	88	26	patients	patient	NOUN
aiua-1760	88	27	.	.	PUNCT
aiua-1760	89	1	prostate	prostate	NOUN
aiua-1760	89	2	cancer	cancer	NOUN
aiua-1760	89	3	prostatic	prostatic	ADJ
aiua-1760	89	4	diseases	disease	NOUN
aiua-1760	89	5	.	.	PUNCT
aiua-1760	90	1	2010	2010	NUM
aiua-1760	90	2	;	;	PUNCT
aiua-1760	90	3	13:316	13:316	NUM
aiua-1760	90	4	-	-	SYM
aiua-1760	90	5	319	319	NUM
aiua-1760	90	6	.	.	PUNCT
aiua-1760	91	1	11	11	NUM
aiua-1760	91	2	.	.	PUNCT
aiua-1760	92	1	pepe	pepe	PROPN
aiua-1760	92	2	p	p	PROPN
aiua-1760	92	3	,	,	PUNCT
aiua-1760	92	4	aragona	aragona	PROPN
aiua-1760	92	5	f.	f.	PROPN
aiua-1760	92	6	saturation	saturation	PROPN
aiua-1760	92	7	prostate	prostate	NOUN
aiua-1760	92	8	needle	needle	NOUN
aiua-1760	92	9	biopsy	biopsy	NOUN
aiua-1760	92	10	and	and	CCONJ
aiua-1760	92	11	prostate	prostate	NOUN
aiua-1760	92	12	cancer	cancer	NOUN
aiua-1760	92	13	detection	detection	NOUN
aiua-1760	92	14	at	at	ADP
aiua-1760	92	15	initial	initial	ADJ
aiua-1760	92	16	and	and	CCONJ
aiua-1760	92	17	repeat	repeat	NOUN
aiua-1760	92	18	evaluation	evaluation	NOUN
aiua-1760	92	19	.	.	PUNCT
aiua-1760	93	1	urology	urology	NOUN
aiua-1760	93	2	.	.	PUNCT
aiua-1760	94	1	2007	2007	NUM
aiua-1760	94	2	;	;	PUNCT
aiua-1760	94	3	70:1131	70:1131	X
aiua-1760	94	4	-	-	SYM
aiua-1760	94	5	1135	1135	NUM
aiua-1760	94	6	.	.	PUNCT
aiua-1760	95	1	12	12	NUM
aiua-1760	95	2	.	.	PUNCT
aiua-1760	95	3	boddy	boddy	PROPN
aiua-1760	95	4	jl	jl	PROPN
aiua-1760	95	5	,	,	PUNCT
aiua-1760	95	6	dev	dev	PROPN
aiua-1760	95	7	s	s	PROPN
aiua-1760	95	8	,	,	PUNCT
aiua-1760	95	9	pike	pike	NOUN
aiua-1760	95	10	dj	dj	NOUN
aiua-1760	95	11	,	,	PUNCT
aiua-1760	95	12	malone	malone	PROPN
aiua-1760	95	13	pr	pr	NOUN
aiua-1760	95	14	.	.	PUNCT
aiua-1760	96	1	intra	intra	ADJ
aiua-1760	96	2	-	-	ADJ
aiua-1760	96	3	individual	individual	ADJ
aiua-1760	96	4	variation	variation	NOUN
aiua-1760	96	5	of	of	ADP
aiua-1760	96	6	serum	serum	NOUN
aiua-1760	96	7	psa	psa	NOUN
aiua-1760	96	8	levels	level	NOUN
aiua-1760	96	9	in	in	ADP
aiua-1760	96	10	men	man	NOUN
aiua-1760	96	11	with	with	ADP
aiua-1760	96	12	benign	benign	ADJ
aiua-1760	96	13	prostate	prostate	NOUN
aiua-1760	96	14	biopsies	biopsy	NOUN
aiua-1760	96	15	.	.	PUNCT
aiua-1760	97	1	bju	bju	PROPN
aiua-1760	97	2	int	int	PROPN
aiua-1760	97	3	.	.	PUNCT
aiua-1760	98	1	2004	2004	NUM
aiua-1760	98	2	;	;	PUNCT
aiua-1760	98	3	93:735	93:735	NUM
aiua-1760	98	4	-	-	SYM
aiua-1760	98	5	38	38	NUM
aiua-1760	98	6	.	.	NOUN
aiua-1760	99	1	13	13	NUM
aiua-1760	99	2	.	.	PUNCT
aiua-1760	100	1	nieder	nieder	PROPN
aiua-1760	100	2	c	c	PROPN
aiua-1760	100	3	,	,	PUNCT
aiua-1760	100	4	norum	norum	PROPN
aiua-1760	100	5	j	j	PROPN
aiua-1760	100	6	,	,	PUNCT
aiua-1760	100	7	geinitz	geinitz	PROPN
aiua-1760	100	8	h.	h.	PROPN
aiua-1760	100	9	impact	impact	NOUN
aiua-1760	100	10	of	of	ADP
aiua-1760	100	11	common	common	ADJ
aiua-1760	100	12	medications	medication	NOUN
aiua-1760	100	13	on	on	ADP
aiua-1760	100	14	serum	serum	NOUN
aiua-1760	100	15	total	total	ADJ
aiua-1760	100	16	psa	psa	NOUN
aiua-1760	100	17	levels	level	NOUN
aiua-1760	100	18	and	and	CCONJ
aiua-1760	100	19	risk	risk	NOUN
aiua-1760	100	20	group	group	NOUN
aiua-1760	100	21	assignment	assignment	NOUN
aiua-1760	100	22	in	in	ADP
aiua-1760	100	23	patients	patient	NOUN
aiua-1760	100	24	with	with	ADP
aiua-1760	100	25	prostate	prostate	NOUN
aiua-1760	100	26	cancer	cancer	NOUN
aiua-1760	100	27	.	.	PUNCT
aiua-1760	101	1	anticancer	anticancer	NOUN
aiua-1760	101	2	research	research	NOUN
aiua-1760	101	3	.	.	PUNCT
aiua-1760	102	1	2011	2011	NUM
aiua-1760	102	2	;	;	PUNCT
aiua-1760	102	3	31:1735	31:1735	NUM
aiua-1760	102	4	-	-	SYM
aiua-1760	102	5	39	39	NUM
aiua-1760	102	6	.	.	PUNCT
aiua-1760	103	1	14	14	NUM
aiua-1760	103	2	.	.	PUNCT
aiua-1760	103	3	steven	steven	PROPN
aiua-1760	103	4	l.	l.	PROPN
aiua-1760	103	5	chang	chang	PROPN
aiua-1760	103	6	,	,	PUNCT
aiua-1760	103	7	lauren	lauren	PROPN
aiua-1760	103	8	c.	c.	PROPN
aiua-1760	103	9	harshman	harshman	PROPN
aiua-1760	103	10	,	,	PUNCT
aiua-1760	103	11	and	and	CCONJ
aiua-1760	103	12	joseph	joseph	PROPN
aiua-1760	103	13	c.	c.	PROPN
aiua-1760	103	14	presti	presti	PROPN
aiua-1760	103	15	jr	jr	PROPN
aiua-1760	103	16	:	:	PUNCT
aiua-1760	103	17	impact	impact	NOUN
aiua-1760	103	18	of	of	ADP
aiua-1760	103	19	common	common	ADJ
aiua-1760	103	20	medications	medication	NOUN
aiua-1760	103	21	on	on	ADP
aiua-1760	103	22	serum	serum	NOUN
aiua-1760	103	23	total	total	ADJ
aiua-1760	103	24	psa	psa	NOUN
aiua-1760	103	25	levels	level	NOUN
aiua-1760	103	26	:	:	PUNCT
aiua-1760	103	27	analysis	analysis	NOUN
aiua-1760	103	28	of	of	ADP
aiua-1760	103	29	the	the	DET
aiua-1760	103	30	national	national	ADJ
aiua-1760	103	31	health	health	PROPN
aiua-1760	103	32	and	and	CCONJ
aiua-1760	103	33	nutrition	nutrition	NOUN
aiua-1760	103	34	examination	examination	NOUN
aiua-1760	103	35	survey	survey	NOUN
aiua-1760	103	36	j	j	PROPN
aiua-1760	103	37	clin	clin	PROPN
aiua-1760	103	38	oncol	oncol	PROPN
aiua-1760	103	39	.	.	PUNCT
aiua-1760	104	1	2010	2010	NUM
aiua-1760	104	2	;	;	PUNCT
aiua-1760	104	3	28:3951	28:3951	NOUN
aiua-1760	104	4	-	-	NOUN
aiua-1760	104	5	3957	3957	NUM
aiua-1760	104	6	.	.	PUNCT
aiua-1760	105	1	15	15	NUM
aiua-1760	105	2	.	.	PUNCT
aiua-1760	105	3	nieder	nieder	PROPN
aiua-1760	105	4	c	c	PROPN
aiua-1760	105	5	,	,	PUNCT
aiua-1760	105	6	norum	norum	PROPN
aiua-1760	105	7	j	j	PROPN
aiua-1760	105	8	,	,	PUNCT
aiua-1760	105	9	geinitz	geinitz	PROPN
aiua-1760	105	10	h.	h.	PROPN
aiua-1760	105	11	impact	impact	NOUN
aiua-1760	105	12	of	of	ADP
aiua-1760	105	13	common	common	ADJ
aiua-1760	105	14	medications	medication	NOUN
aiua-1760	105	15	els	el	NOUN
aiua-1760	105	16	of	of	ADP
aiua-1760	105	17	36	36	NUM
aiua-1760	105	18	%	%	NOUN
aiua-1760	105	19	after	after	ADP
aiua-1760	105	20	5	5	NUM
aiua-1760	105	21	years	year	NOUN
aiua-1760	105	22	of	of	ADP
aiua-1760	105	23	combined	combined	ADJ
aiua-1760	105	24	therapy	therapy	NOUN
aiua-1760	105	25	(	(	PUNCT
aiua-1760	105	26	13	13	NUM
aiua-1760	105	27	-	-	SYM
aiua-1760	105	28	15	15	NUM
aiua-1760	105	29	)	)	PUNCT
aiua-1760	105	30	.	.	PUNCT
aiua-1760	106	1	prostatitis	prostatitis	NOUN
aiua-1760	106	2	is	be	AUX
aiua-1760	106	3	responsible	responsible	ADJ
aiua-1760	106	4	for	for	ADP
aiua-1760	106	5	falsely	falsely	ADV
aiua-1760	106	6	elevated	elevate	VERB
aiua-1760	106	7	psa	psa	NOUN
aiua-1760	106	8	levels	level	NOUN
aiua-1760	106	9	,	,	PUNCT
aiua-1760	106	10	but	but	CCONJ
aiua-1760	106	11	it	it	PRON
aiua-1760	106	12	remains	remain	VERB
aiua-1760	106	13	unclear	unclear	ADJ
aiua-1760	106	14	in	in	ADP
aiua-1760	106	15	which	which	PRON
aiua-1760	106	16	patients	patient	NOUN
aiua-1760	106	17	we	we	PRON
aiua-1760	106	18	can	can	AUX
aiua-1760	106	19	avoid	avoid	VERB
aiua-1760	106	20	repeat	repeat	NOUN
aiua-1760	106	21	biopsy	biopsy	NOUN
aiua-1760	106	22	without	without	ADP
aiua-1760	106	23	underestimating	underestimate	VERB
aiua-1760	106	24	the	the	DET
aiua-1760	106	25	risk	risk	NOUN
aiua-1760	106	26	of	of	ADP
aiua-1760	106	27	cancer	cancer	NOUN
aiua-1760	106	28	(	(	PUNCT
aiua-1760	106	29	16	16	NUM
aiua-1760	106	30	)	)	PUNCT
aiua-1760	106	31	.	.	PUNCT
aiua-1760	107	1	singer	singer	NOUN
aiua-1760	107	2	et	et	PROPN
aiua-1760	107	3	al	al	PROPN
aiua-1760	107	4	.	.	PROPN
aiua-1760	108	1	(	(	PUNCT
aiua-1760	108	2	17	17	NUM
aiua-1760	108	3	)	)	PUNCT
aiua-1760	108	4	in	in	ADP
aiua-1760	108	5	1319	1319	NUM
aiua-1760	108	6	men	man	NOUN
aiua-1760	108	7	aged	age	VERB
aiua-1760	108	8	>	>	X
aiua-1760	108	9	40	40	NUM
aiua-1760	108	10	years	year	NOUN
aiua-1760	108	11	observed	observe	VERB
aiua-1760	108	12	that	that	SCONJ
aiua-1760	108	13	psa	psa	NOUN
aiua-1760	108	14	levels	level	NOUN
aiua-1760	108	15	were	be	AUX
aiua-1760	108	16	24	24	NUM
aiua-1760	108	17	%	%	NOUN
aiua-1760	108	18	lower	low	ADJ
aiua-1760	108	19	among	among	ADP
aiua-1760	108	20	acetaminophen	acetaminophen	NOUN
aiua-1760	108	21	users	user	NOUN
aiua-1760	108	22	compared	compare	VERB
aiua-1760	108	23	with	with	ADP
aiua-1760	108	24	non	non	ADJ
aiua-1760	108	25	drug	drug	NOUN
aiua-1760	108	26	takers	taker	NOUN
aiua-1760	108	27	.	.	PUNCT
aiua-1760	109	1	several	several	ADJ
aiua-1760	109	2	systematic	systematic	ADJ
aiua-1760	109	3	reviews	review	NOUN
aiua-1760	109	4	have	have	AUX
aiua-1760	109	5	examined	examine	VERB
aiua-1760	109	6	the	the	DET
aiua-1760	109	7	relationship	relationship	NOUN
aiua-1760	109	8	between	between	ADP
aiua-1760	109	9	nsaid	nsaid	PROPN
aiua-1760	109	10	/	/	SYM
aiua-1760	109	11	aspirin	aspirin	NOUN
aiua-1760	109	12	consumption	consumption	NOUN
aiua-1760	109	13	and	and	CCONJ
aiua-1760	109	14	the	the	DET
aiua-1760	109	15	risk	risk	NOUN
aiua-1760	109	16	of	of	ADP
aiua-1760	109	17	developing	develop	VERB
aiua-1760	109	18	pca	pca	PROPN
aiua-1760	109	19	.	.	PUNCT
aiua-1760	110	1	mahmud	mahmud	PROPN
aiua-1760	110	2	et	et	PROPN
aiua-1760	110	3	al	al	PROPN
aiua-1760	110	4	.	.	PROPN
aiua-1760	111	1	(	(	PUNCT
aiua-1760	111	2	18	18	NUM
aiua-1760	111	3	)	)	PUNCT
aiua-1760	111	4	in	in	ADP
aiua-1760	111	5	a	a	DET
aiua-1760	111	6	meta	meta	ADJ
aiua-1760	111	7	-	-	PUNCT
aiua-1760	111	8	analysis	analysis	NOUN
aiua-1760	111	9	found	find	VERB
aiua-1760	111	10	that	that	SCONJ
aiua-1760	111	11	aspirin	aspirin	NOUN
aiua-1760	111	12	use	use	NOUN
aiua-1760	111	13	provided	provide	VERB
aiua-1760	111	14	a	a	DET
aiua-1760	111	15	10	10	NUM
aiua-1760	111	16	%	%	NOUN
aiua-1760	111	17	risk	risk	NOUN
aiua-1760	111	18	reduction	reduction	NOUN
aiua-1760	111	19	for	for	ADP
aiua-1760	111	20	pca	pca	NOUN
aiua-1760	111	21	and	and	CCONJ
aiua-1760	111	22	a	a	DET
aiua-1760	111	23	30	30	NUM
aiua-1760	111	24	%	%	NOUN
aiua-1760	111	25	risk	risk	NOUN
aiua-1760	111	26	reduction	reduction	NOUN
aiua-1760	111	27	for	for	ADP
aiua-1760	111	28	advanced	advanced	ADJ
aiua-1760	111	29	disease	disease	NOUN
aiua-1760	111	30	.	.	PUNCT
aiua-1760	112	1	harris	harris	PROPN
aiua-1760	112	2	et	et	PROPN
aiua-1760	112	3	al	al	PROPN
aiua-1760	112	4	.	.	PROPN
aiua-1760	113	1	(	(	PUNCT
aiua-1760	113	2	19	19	NUM
aiua-1760	113	3	)	)	PUNCT
aiua-1760	113	4	and	and	CCONJ
aiua-1760	113	5	jacobs	jacobs	PROPN
aiua-1760	113	6	et	et	PROPN
aiua-1760	113	7	al	al	PROPN
aiua-1760	113	8	.	.	PROPN
aiua-1760	114	1	(	(	PUNCT
aiua-1760	114	2	20	20	NUM
aiua-1760	114	3	)	)	PUNCT
aiua-1760	114	4	reported	report	VERB
aiua-1760	114	5	that	that	SCONJ
aiua-1760	114	6	daily	daily	PROPN
aiua-1760	114	7	nsaid	nsaid	PROPN
aiua-1760	114	8	use	use	NOUN
aiua-1760	114	9	(	(	PUNCT
aiua-1760	114	10	including	include	VERB
aiua-1760	114	11	aspirin	aspirin	NOUN
aiua-1760	114	12	)	)	PUNCT
aiua-1760	114	13	was	be	AUX
aiua-1760	114	14	associated	associate	VERB
aiua-1760	114	15	with	with	ADP
aiua-1760	114	16	a	a	DET
aiua-1760	114	17	39	39	NUM
aiua-1760	114	18	%	%	NOUN
aiua-1760	114	19	and	and	CCONJ
aiua-1760	114	20	20	20	NUM
aiua-1760	114	21	%	%	NOUN
aiua-1760	114	22	risk	risk	NOUN
aiua-1760	114	23	reduction	reduction	NOUN
aiua-1760	114	24	for	for	ADP
aiua-1760	114	25	pca	pca	PROPN
aiua-1760	114	26	,	,	PUNCT
aiua-1760	114	27	respectively	respectively	ADV
aiua-1760	114	28	.	.	PUNCT
aiua-1760	115	1	engelhardt	engelhardt	PROPN
aiua-1760	115	2	and	and	CCONJ
aiua-1760	115	3	rjedl	rjedl	PROPN
aiua-1760	115	4	(	(	PUNCT
aiua-1760	115	5	21	21	NUM
aiua-1760	115	6	)	)	PUNCT
aiua-1760	115	7	reported	report	VERB
aiua-1760	115	8	in	in	ADP
aiua-1760	115	9	20	20	NUM
aiua-1760	115	10	patients	patient	NOUN
aiua-1760	115	11	,	,	PUNCT
aiua-1760	115	12	assuming	assume	VERB
aiua-1760	115	13	a	a	DET
aiua-1760	115	14	daily	daily	ADJ
aiua-1760	115	15	dose	dose	NOUN
aiua-1760	115	16	(	(	PUNCT
aiua-1760	115	17	60	60	NUM
aiua-1760	115	18	mg	mg	NOUN
aiua-1760	115	19	)	)	PUNCT
aiua-1760	115	20	of	of	ADP
aiua-1760	115	21	an	an	DET
aiua-1760	115	22	isoflavone	isoflavone	NOUN
aiua-1760	115	23	extract	extract	NOUN
aiua-1760	115	24	for	for	ADP
aiua-1760	115	25	1	1	NUM
aiua-1760	115	26	year	year	NOUN
aiua-1760	115	27	,	,	PUNCT
aiua-1760	115	28	a	a	DET
aiua-1760	115	29	psa	psa	NOUN
aiua-1760	115	30	reduction	reduction	NOUN
aiua-1760	115	31	of	of	ADP
aiua-1760	115	32	33	33	NUM
aiua-1760	115	33	%	%	NOUN
aiua-1760	115	34	combined	combine	VERB
aiua-1760	115	35	with	with	ADP
aiua-1760	115	36	a	a	DET
aiua-1760	115	37	significant	significant	ADJ
aiua-1760	115	38	increase	increase	NOUN
aiua-1760	115	39	in	in	ADP
aiua-1760	115	40	hepatic	hepatic	ADJ
aiua-1760	115	41	transaminases	transaminase	NOUN
aiua-1760	115	42	.	.	PUNCT
aiua-1760	116	1	all	all	DET
aiua-1760	116	2	these	these	DET
aiua-1760	116	3	studies	study	NOUN
aiua-1760	116	4	agree	agree	VERB
aiua-1760	116	5	that	that	SCONJ
aiua-1760	116	6	the	the	DET
aiua-1760	116	7	reduction	reduction	NOUN
aiua-1760	116	8	in	in	ADP
aiua-1760	116	9	psa	psa	NOUN
aiua-1760	116	10	levels	level	NOUN
aiua-1760	116	11	due	due	ADJ
aiua-1760	116	12	to	to	ADP
aiua-1760	116	13	anti	anti	ADJ
aiua-1760	116	14	-	-	ADJ
aiua-1760	116	15	inflammatory	inflammatory	ADJ
aiua-1760	116	16	therapy	therapy	NOUN
aiua-1760	116	17	may	may	AUX
aiua-1760	116	18	reduce	reduce	VERB
aiua-1760	116	19	the	the	DET
aiua-1760	116	20	number	number	NOUN
aiua-1760	116	21	of	of	ADP
aiua-1760	116	22	men	man	NOUN
aiua-1760	116	23	referred	refer	VERB
aiua-1760	116	24	for	for	ADP
aiua-1760	116	25	prostate	prostate	NOUN
aiua-1760	116	26	biopsy	biopsy	NOUN
aiua-1760	116	27	decreasing	decrease	VERB
aiua-1760	116	28	the	the	DET
aiua-1760	116	29	number	number	NOUN
aiua-1760	116	30	of	of	ADP
aiua-1760	116	31	men	man	NOUN
aiua-1760	116	32	diagnosed	diagnose	VERB
aiua-1760	116	33	with	with	ADP
aiua-1760	116	34	pca	pca	PROPN
aiua-1760	116	35	.	.	PUNCT
aiua-1760	117	1	however	however	ADV
aiua-1760	117	2	,	,	PUNCT
aiua-1760	117	3	a	a	DET
aiua-1760	117	4	clear	clear	ADJ
aiua-1760	117	5	correlation	correlation	NOUN
aiua-1760	117	6	between	between	ADP
aiua-1760	117	7	nsaids	nsaid	NOUN
aiua-1760	117	8	,	,	PUNCT
aiua-1760	117	9	serum	serum	NOUN
aiua-1760	117	10	psa	psa	NOUN
aiua-1760	117	11	and	and	CCONJ
aiua-1760	117	12	risk	risk	NOUN
aiua-1760	117	13	of	of	ADP
aiua-1760	117	14	missing	miss	VERB
aiua-1760	117	15	a	a	DET
aiua-1760	117	16	pca	pca	NOUN
aiua-1760	117	17	diagnosis	diagnosis	NOUN
aiua-1760	117	18	is	be	AUX
aiua-1760	117	19	still	still	ADV
aiua-1760	117	20	unknown	unknown	ADJ
aiua-1760	117	21	(	(	PUNCT
aiua-1760	117	22	16	16	NUM
aiua-1760	117	23	)	)	PUNCT
aiua-1760	117	24	.	.	PUNCT
aiua-1760	118	1	in	in	ADP
aiua-1760	118	2	our	our	PRON
aiua-1760	118	3	study	study	NOUN
aiua-1760	118	4	,	,	PUNCT
aiua-1760	118	5	we	we	PRON
aiua-1760	118	6	used	use	VERB
aiua-1760	118	7	as	as	ADP
aiua-1760	118	8	anti	anti	ADJ
aiua-1760	118	9	-	-	ADJ
aiua-1760	118	10	inflammatory	inflammatory	ADJ
aiua-1760	118	11	agent	agent	NOUN
aiua-1760	118	12	a	a	DET
aiua-1760	118	13	mixture	mixture	NOUN
aiua-1760	118	14	of	of	ADP
aiua-1760	118	15	herbal	herbal	ADJ
aiua-1760	118	16	extract	extract	NOUN
aiua-1760	118	17	(	(	PUNCT
aiua-1760	118	18	lenidase	lenidase	NOUN
aiua-1760	118	19	®	®	PROPN
aiua-1760	118	20	)	)	PUNCT
aiua-1760	118	21	which	which	PRON
aiua-1760	118	22	has	have	VERB
aiua-1760	118	23	a	a	DET
aiua-1760	118	24	demonstrated	demonstrate	VERB
aiua-1760	118	25	antiedematous	antiedematous	ADJ
aiua-1760	118	26	and	and	CCONJ
aiua-1760	118	27	anti	anti	ADJ
aiua-1760	118	28	-	-	ADJ
aiua-1760	118	29	inflammatory	inflammatory	ADJ
aiua-1760	118	30	activity	activity	NOUN
aiua-1760	118	31	.	.	PUNCT
aiua-1760	119	1	each	each	DET
aiua-1760	119	2	tablet	tablet	NOUN
aiua-1760	119	3	contains	contain	VERB
aiua-1760	119	4	:	:	PUNCT
aiua-1760	119	5	baicalina	baicalina	NOUN
aiua-1760	119	6	(	(	PUNCT
aiua-1760	119	7	190	190	NUM
aiua-1760	119	8	mg	mg	NOUN
aiua-1760	119	9	)	)	PUNCT
aiua-1760	119	10	,	,	PUNCT
aiua-1760	119	11	a	a	DET
aiua-1760	119	12	flavonoid	flavonoid	NOUN
aiua-1760	119	13	from	from	ADP
aiua-1760	119	14	scutellaria	scutellaria	NOUN
aiua-1760	119	15	baicalensis	baicalensis	NOUN
aiua-1760	119	16	that	that	PRON
aiua-1760	119	17	inhibits	inhibit	VERB
aiua-1760	119	18	5	5	NUM
aiua-1760	119	19	-	-	NOUN
aiua-1760	119	20	lipoxygenase	lipoxygenase	NOUN
aiua-1760	119	21	(	(	PUNCT
aiua-1760	119	22	5	5	NUM
aiua-1760	119	23	-	-	PUNCT
aiua-1760	119	24	lox	lox	NOUN
aiua-1760	119	25	)	)	PUNCT
aiua-1760	119	26	and	and	CCONJ
aiua-1760	119	27	cox	cox	PROPN
aiua-1760	119	28	activities	activity	NOUN
aiua-1760	119	29	and	and	CCONJ
aiua-1760	119	30	leukotriene	leukotriene	NOUN
aiua-1760	119	31	synthesis	synthesis	NOUN
aiua-1760	119	32	(	(	PUNCT
aiua-1760	119	33	22	22	NUM
aiua-1760	119	34	-	-	SYM
aiua-1760	119	35	24	24	NUM
aiua-1760	119	36	)	)	PUNCT
aiua-1760	119	37	;	;	PUNCT
aiua-1760	119	38	bromelina	bromelina	NOUN
aiua-1760	119	39	(	(	PUNCT
aiua-1760	119	40	50	50	NUM
aiua-1760	119	41	mg	mg	NOUN
aiua-1760	119	42	)	)	PUNCT
aiua-1760	119	43	,	,	PUNCT
aiua-1760	119	44	extract	extract	VERB
aiua-1760	119	45	from	from	ADP
aiua-1760	119	46	ananas	ananas	PROPN
aiua-1760	119	47	comosus	comosus	PROPN
aiua-1760	119	48	,	,	PUNCT
aiua-1760	119	49	that	that	PRON
aiua-1760	119	50	is	be	AUX
aiua-1760	119	51	an	an	DET
aiua-1760	119	52	enzymatic	enzymatic	ADJ
aiua-1760	119	53	anti	anti	ADJ
aiua-1760	119	54	-	-	ADJ
aiua-1760	119	55	inflammatory	inflammatory	ADJ
aiua-1760	119	56	agent	agent	NOUN
aiua-1760	119	57	and	and	CCONJ
aiua-1760	119	58	escina	escina	NOUN
aiua-1760	119	59	(	(	PUNCT
aiua-1760	119	60	30	30	NUM
aiua-1760	119	61	mg	mg	NUM
aiua-1760	119	62	)	)	PUNCT
aiua-1760	119	63	,	,	PUNCT
aiua-1760	119	64	extract	extract	VERB
aiua-1760	119	65	from	from	ADP
aiua-1760	119	66	aesculus	aesculus	ADJ
aiua-1760	119	67	hyppocastanum	hyppocastanum	ADJ
aiua-1760	119	68	,	,	PUNCT
aiua-1760	119	69	that	that	PRON
aiua-1760	119	70	has	have	VERB
aiua-1760	119	71	an	an	DET
aiua-1760	119	72	antiedemigenous	antiedemigenous	ADJ
aiua-1760	119	73	effect	effect	NOUN
aiua-1760	119	74	and	and	CCONJ
aiua-1760	119	75	enhances	enhance	VERB
aiua-1760	119	76	corticosteroid	corticosteroid	ADJ
aiua-1760	119	77	receptors	receptor	NOUN
aiua-1760	119	78	activity	activity	NOUN
aiua-1760	119	79	.	.	PUNCT
aiua-1760	120	1	a	a	DET
aiua-1760	120	2	median	median	ADJ
aiua-1760	120	3	psa	psa	NOUN
aiua-1760	120	4	reduction	reduction	NOUN
aiua-1760	120	5	of	of	ADP
aiua-1760	120	6	about	about	ADV
aiua-1760	120	7	20	20	NUM
aiua-1760	120	8	%	%	NOUN
aiua-1760	120	9	was	be	AUX
aiua-1760	120	10	observed	observe	VERB
aiua-1760	120	11	in	in	ADP
aiua-1760	120	12	54/70	54/70	NUM
aiua-1760	120	13	(	(	PUNCT
aiua-1760	120	14	77.2	77.2	NUM
aiua-1760	120	15	%	%	NOUN
aiua-1760	120	16	)	)	PUNCT
aiua-1760	120	17	patients	patient	NOUN
aiua-1760	120	18	assuming	assume	VERB
aiua-1760	120	19	lenidase	lenidase	NOUN
aiua-1760	120	20	®	®	PROPN
aiua-1760	120	21	.	.	PUNCT
aiua-1760	121	1	in	in	ADP
aiua-1760	121	2	details	detail	NOUN
aiua-1760	121	3	,	,	PUNCT
aiua-1760	121	4	15	15	NUM
aiua-1760	121	5	(	(	PUNCT
aiua-1760	121	6	28.5	28.5	NUM
aiua-1760	121	7	%	%	NOUN
aiua-1760	121	8	)	)	PUNCT
aiua-1760	121	9	men	man	NOUN
aiua-1760	121	10	reached	reach	VERB
aiua-1760	121	11	a	a	DET
aiua-1760	121	12	psa	psa	NOUN
aiua-1760	121	13	value	value	NOUN
aiua-1760	121	14	<	<	X
aiua-1760	121	15	4	4	NUM
aiua-1760	121	16	ng	ng	NOUN
aiua-1760	121	17	/	/	SYM
aiua-1760	121	18	ml	ml	PROPN
aiua-1760	121	19	and	and	CCONJ
aiua-1760	121	20	the	the	DET
aiua-1760	121	21	repeat	repeat	NOUN
aiua-1760	121	22	spbx	spbx	PROPN
aiua-1760	121	23	rate	rate	NOUN
aiua-1760	121	24	resulted	result	VERB
aiua-1760	121	25	significantly	significantly	ADV
aiua-1760	121	26	lower	low	ADJ
aiua-1760	121	27	in	in	ADP
aiua-1760	121	28	comparison	comparison	NOUN
aiua-1760	121	29	with	with	ADP
aiua-1760	121	30	our	our	PRON
aiua-1760	121	31	previous	previous	ADJ
aiua-1760	121	32	data	datum	NOUN
aiua-1760	121	33	(	(	PUNCT
aiua-1760	121	34	22.8	22.8	NUM
aiua-1760	121	35	%	%	NOUN
aiua-1760	121	36	vs	vs	ADP
aiua-1760	121	37	35.5	35.5	NUM
aiua-1760	121	38	%	%	NOUN
aiua-1760	121	39	;	;	PUNCT
aiua-1760	121	40	p	p	X
aiua-1760	121	41	<	<	X
aiua-1760	121	42	0.05	0.05	NUM
aiua-1760	121	43	)	)	PUNCT
aiua-1760	121	44	showing	show	VERB
aiua-1760	121	45	a	a	DET
aiua-1760	121	46	superimposable	superimposable	ADJ
aiua-1760	121	47	detection	detection	NOUN
aiua-1760	121	48	rate	rate	NOUN
aiua-1760	121	49	for	for	ADP
aiua-1760	121	50	cancer	cancer	NOUN
aiua-1760	121	51	(	(	PUNCT
aiua-1760	121	52	18.7	18.7	NUM
aiua-1760	121	53	%	%	NOUN
aiua-1760	121	54	vs	vs	ADP
aiua-1760	121	55	22	22	NUM
aiua-1760	121	56	%	%	NOUN
aiua-1760	121	57	)	)	PUNCT
aiua-1760	121	58	.	.	PUNCT
aiua-1760	122	1	therefore	therefore	ADV
aiua-1760	122	2	,	,	PUNCT
aiua-1760	122	3	the	the	DET
aiua-1760	122	4	significantly	significantly	ADJ
aiua-1760	122	5	reduction	reduction	NOUN
aiua-1760	122	6	of	of	ADP
aiua-1760	122	7	psa	psa	NOUN
aiua-1760	122	8	levels	level	NOUN
aiua-1760	122	9	in	in	ADP
aiua-1760	122	10	comparison	comparison	NOUN
aiua-1760	122	11	with	with	ADP
aiua-1760	122	12	physiological	physiological	ADJ
aiua-1760	122	13	psa	psa	NOUN
aiua-1760	122	14	fluctuations	fluctuation	NOUN
aiua-1760	122	15	(	(	PUNCT
aiua-1760	122	16	12	12	NUM
aiua-1760	122	17	)	)	PUNCT
aiua-1760	122	18	and	and	CCONJ
aiua-1760	122	19	the	the	DET
aiua-1760	122	20	absence	absence	NOUN
aiua-1760	122	21	of	of	ADP
aiua-1760	122	22	reliable	reliable	ADJ
aiua-1760	122	23	criteria	criterion	NOUN
aiua-1760	122	24	to	to	PART
aiua-1760	122	25	select	select	VERB
aiua-1760	122	26	patients	patient	NOUN
aiua-1760	122	27	at	at	ADP
aiua-1760	122	28	risk	risk	NOUN
aiua-1760	122	29	for	for	ADP
aiua-1760	122	30	pca	pca	PROPN
aiua-1760	122	31	seems	seem	VERB
aiua-1760	122	32	to	to	PART
aiua-1760	122	33	suggest	suggest	VERB
aiua-1760	122	34	a	a	DET
aiua-1760	122	35	prolonged	prolonged	ADJ
aiua-1760	122	36	trial	trial	NOUN
aiua-1760	122	37	of	of	ADP
aiua-1760	122	38	anti	anti	ADJ
aiua-1760	122	39	-	-	ADJ
aiua-1760	122	40	inflammatory	inflammatory	ADJ
aiua-1760	122	41	therapy	therapy	NOUN
aiua-1760	122	42	before	before	ADP
aiua-1760	122	43	taking	take	VERB
aiua-1760	122	44	any	any	DET
aiua-1760	122	45	decision	decision	NOUN
aiua-1760	122	46	in	in	ADP
aiua-1760	122	47	patients	patient	NOUN
aiua-1760	122	48	with	with	ADP
aiua-1760	122	49	negative	negative	ADJ
aiua-1760	122	50	prostate	prostate	NOUN
aiua-1760	122	51	biopsy	biopsy	NOUN
aiua-1760	122	52	and	and	CCONJ
aiua-1760	122	53	persistently	persistently	ADV
aiua-1760	122	54	elevated	elevated	ADJ
aiua-1760	122	55	psa	psa	NOUN
aiua-1760	122	56	levels	level	NOUN
aiua-1760	122	57	.	.	PUNCT
aiua-1760	123	1	our	our	PRON
aiua-1760	123	2	results	result	NOUN
aiua-1760	123	3	deserve	deserve	VERB
aiua-1760	123	4	some	some	DET
aiua-1760	123	5	considerations	consideration	NOUN
aiua-1760	123	6	.	.	PUNCT
aiua-1760	124	1	firstly	firstly	ADV
aiua-1760	124	2	,	,	PUNCT
aiua-1760	124	3	the	the	DET
aiua-1760	124	4	absence	absence	NOUN
aiua-1760	124	5	of	of	ADP
aiua-1760	124	6	a	a	DET
aiua-1760	124	7	placebo	placebo	NOUN
aiua-1760	124	8	control	control	NOUN
aiua-1760	124	9	group	group	NOUN
aiua-1760	124	10	;	;	PUNCT
aiua-1760	124	11	for	for	ADP
aiua-1760	124	12	our	our	PRON
aiua-1760	124	13	purpose	purpose	NOUN
aiua-1760	124	14	,	,	PUNCT
aiua-1760	124	15	we	we	PRON
aiua-1760	124	16	used	use	VERB
aiua-1760	124	17	as	as	ADP
aiua-1760	124	18	a	a	DET
aiua-1760	124	19	surrogate	surrogate	NOUN
aiua-1760	124	20	our	our	PRON
aiua-1760	124	21	previously	previously	ADV
aiua-1760	124	22	recorded	record	VERB
aiua-1760	124	23	cases	case	NOUN
aiua-1760	124	24	.	.	PUNCT
aiua-1760	125	1	secondly	secondly	ADV
aiua-1760	125	2	,	,	PUNCT
aiua-1760	125	3	it	it	PRON
aiua-1760	125	4	is	be	AUX
aiua-1760	125	5	unknown	unknown	ADJ
aiua-1760	125	6	if	if	SCONJ
aiua-1760	125	7	psa	psa	NOUN
aiua-1760	125	8	reduction	reduction	NOUN
aiua-1760	125	9	is	be	AUX
aiua-1760	125	10	uniquely	uniquely	ADV
aiua-1760	125	11	secondary	secondary	ADJ
aiua-1760	125	12	to	to	ADP
aiua-1760	125	13	the	the	DET
aiua-1760	125	14	anti	anti	ADJ
aiua-1760	125	15	-	-	ADJ
aiua-1760	125	16	inflammatory	inflammatory	ADJ
aiua-1760	125	17	activity	activity	NOUN
aiua-1760	125	18	or	or	CCONJ
aiua-1760	125	19	is	be	AUX
aiua-1760	125	20	in	in	ADP
aiua-1760	125	21	some	some	DET
aiua-1760	125	22	way	way	NOUN
aiua-1760	125	23	influenced	influence	VERB
aiua-1760	125	24	by	by	ADP
aiua-1760	125	25	anti	anti	ADJ
aiua-1760	125	26	-	-	ADJ
aiua-1760	125	27	proliferative	proliferative	ADJ
aiua-1760	125	28	effects	effect	NOUN
aiua-1760	125	29	of	of	ADP
aiua-1760	125	30	baicalina	baicalina	NOUN
aiua-1760	125	31	(	(	PUNCT
aiua-1760	125	32	25	25	NUM
aiua-1760	125	33	)	)	PUNCT
aiua-1760	125	34	;	;	PUNCT
aiua-1760	125	35	thirdly	thirdly	ADV
aiua-1760	125	36	,	,	PUNCT
aiua-1760	125	37	pca	pca	NOUN
aiua-1760	125	38	incidence	incidence	NOUN
aiua-1760	125	39	is	be	AUX
aiua-1760	125	40	available	available	ADJ
aiua-1760	125	41	only	only	ADV
aiua-1760	125	42	in	in	ADP
aiua-1760	125	43	patients	patient	NOUN
aiua-1760	125	44	whose	whose	DET
aiua-1760	125	45	psa	psa	NOUN
aiua-1760	125	46	levels	level	NOUN
aiua-1760	125	47	remained	remain	VERB
aiua-1760	125	48	unchanged	unchanged	ADJ
aiua-1760	125	49	after	after	ADP
aiua-1760	125	50	anti	anti	ADJ
aiua-1760	125	51	-	-	ADJ
aiua-1760	125	52	inflammatory	inflammatory	ADJ
aiua-1760	125	53	trial	trial	NOUN
aiua-1760	125	54	(	(	PUNCT
aiua-1760	125	55	the	the	DET
aiua-1760	125	56	risk	risk	NOUN
aiua-1760	125	57	of	of	ADP
aiua-1760	125	58	missing	miss	VERB
aiua-1760	125	59	pca	pca	NOUN
aiua-1760	125	60	diagnosis	diagnosis	NOUN
aiua-1760	125	61	in	in	ADP
aiua-1760	125	62	men	man	NOUN
aiua-1760	125	63	with	with	ADP
aiua-1760	125	64	decreased	decrease	VERB
aiua-1760	125	65	psa	psa	NOUN
aiua-1760	125	66	is	be	AUX
aiua-1760	125	67	actually	actually	ADV
aiua-1760	125	68	unknown	unknown	ADJ
aiua-1760	125	69	)	)	PUNCT
aiua-1760	125	70	.	.	PUNCT
aiua-1760	126	1	finally	finally	ADV
aiua-1760	126	2	,	,	PUNCT
aiua-1760	126	3	a	a	DET
aiua-1760	126	4	greater	great	ADJ
aiua-1760	126	5	number	number	NOUN
aiua-1760	126	6	of	of	ADP
aiua-1760	126	7	patients	patient	NOUN
aiua-1760	126	8	and	and	CCONJ
aiua-1760	126	9	a	a	DET
aiua-1760	126	10	longer	long	ADV
aiua-1760	126	11	follow	follow	VERB
aiua-1760	126	12	up	up	ADP
aiua-1760	126	13	are	be	AUX
aiua-1760	126	14	necessary	necessary	ADJ
aiua-1760	126	15	to	to	PART
aiua-1760	126	16	confirm	confirm	VERB
aiua-1760	126	17	our	our	PRON
aiua-1760	126	18	results	result	NOUN
aiua-1760	126	19	.	.	PUNCT
aiua-1760	127	1	in	in	ADP
aiua-1760	127	2	conclusion	conclusion	NOUN
aiua-1760	127	3	,	,	PUNCT
aiua-1760	127	4	in	in	ADP
aiua-1760	127	5	our	our	PRON
aiua-1760	127	6	preliminary	preliminary	ADJ
aiua-1760	127	7	data	datum	NOUN
aiua-1760	127	8	a	a	DET
aiua-1760	127	9	prolonged	prolonged	ADJ
aiua-1760	127	10	oral	oral	ADJ
aiua-1760	127	11	candiano_stesura	candiano_stesura	ADJ
aiua-1760	127	12	seveso	seveso	NOUN
aiua-1760	127	13	24/06/13	24/06/13	PROPN
aiua-1760	127	14	10:59	10:59	NUM
aiua-1760	127	15	pagina	pagina	NOUN
aiua-1760	127	16	67	67	NUM
aiua-1760	127	17	archivio	archivio	NOUN
aiua-1760	127	18	italiano	italiano	X
aiua-1760	127	19	di	di	X
aiua-1760	127	20	urologia	urologia	PROPN
aiua-1760	127	21	e	e	PROPN
aiua-1760	127	22	andrologia	andrologia	NOUN
aiua-1760	127	23	2013	2013	NUM
aiua-1760	127	24	;	;	PUNCT
aiua-1760	127	25	85	85	NUM
aiua-1760	127	26	,	,	PUNCT
aiua-1760	127	27	2	2	NUM
aiua-1760	127	28	g.	g.	NOUN
aiua-1760	127	29	candiano	candiano	PROPN
aiua-1760	127	30	,	,	PUNCT
aiua-1760	127	31	p.	p.	PROPN
aiua-1760	127	32	pepe	pepe	PROPN
aiua-1760	127	33	,	,	PUNCT
aiua-1760	127	34	f.	f.	PROPN
aiua-1760	127	35	pietropaolo	pietropaolo	PROPN
aiua-1760	127	36	,	,	PUNCT
aiua-1760	127	37	f.	f.	PROPN
aiua-1760	127	38	aragona	aragona	PROPN
aiua-1760	127	39	68	68	NUM
aiua-1760	127	40	on	on	ADP
aiua-1760	127	41	serum	serum	NOUN
aiua-1760	127	42	total	total	ADJ
aiua-1760	127	43	psa	psa	NOUN
aiua-1760	127	44	levels	level	NOUN
aiua-1760	127	45	and	and	CCONJ
aiua-1760	127	46	risk	risk	NOUN
aiua-1760	127	47	group	group	NOUN
aiua-1760	127	48	assignment	assignment	NOUN
aiua-1760	127	49	in	in	ADP
aiua-1760	127	50	patients	patient	NOUN
aiua-1760	127	51	with	with	ADP
aiua-1760	127	52	prostate	prostate	NOUN
aiua-1760	127	53	cancer	cancer	NOUN
aiua-1760	127	54	.	.	PUNCT
aiua-1760	128	1	anticancer	anticancer	NOUN
aiua-1760	128	2	res	re	NOUN
aiua-1760	128	3	.	.	PUNCT
aiua-1760	128	4	2011	2011	NUM
aiua-1760	128	5	;	;	PUNCT
aiua-1760	128	6	31:1735	31:1735	NUM
aiua-1760	128	7	-	-	SYM
aiua-1760	128	8	39	39	NUM
aiua-1760	128	9	.	.	PUNCT
aiua-1760	129	1	16	16	NUM
aiua-1760	129	2	.	.	PUNCT
aiua-1760	129	3	platz	platz	PROPN
aiua-1760	129	4	ea	ea	PROPN
aiua-1760	129	5	,	,	PUNCT
aiua-1760	129	6	rohrmann	rohrmann	PROPN
aiua-1760	129	7	s	s	PROPN
aiua-1760	129	8	,	,	PUNCT
aiua-1760	129	9	pearson	pearson	PROPN
aiua-1760	129	10	jd	jd	PROPN
aiua-1760	129	11	,	,	PUNCT
aiua-1760	129	12	et	et	PROPN
aiua-1760	129	13	al	al	PROPN
aiua-1760	129	14	.	.	PROPN
aiua-1760	129	15	nonsteroidal	nonsteroidal	NOUN
aiua-1760	129	16	antiinflammatory	antiinflammatory	NOUN
aiua-1760	129	17	drugs	drug	NOUN
aiua-1760	129	18	and	and	CCONJ
aiua-1760	129	19	risk	risk	NOUN
aiua-1760	129	20	of	of	ADP
aiua-1760	129	21	prostate	prostate	NOUN
aiua-1760	129	22	cancer	cancer	NOUN
aiua-1760	129	23	in	in	ADP
aiua-1760	129	24	the	the	DET
aiua-1760	129	25	baltimore	baltimore	PROPN
aiua-1760	129	26	longitudinal	longitudinal	ADJ
aiua-1760	129	27	study	study	NOUN
aiua-1760	129	28	of	of	ADP
aiua-1760	129	29	aging	aging	NOUN
aiua-1760	129	30	.	.	PUNCT
aiua-1760	130	1	cancer	cancer	NOUN
aiua-1760	130	2	epidemiol	epidemiol	PROPN
aiua-1760	130	3	biomarkers	biomarkers	PROPN
aiua-1760	130	4	prev	prev	X
aiua-1760	130	5	.	.	PUNCT
aiua-1760	131	1	2005	2005	NUM
aiua-1760	131	2	;	;	PUNCT
aiua-1760	131	3	14:390	14:390	NUM
aiua-1760	131	4	-	-	SYM
aiua-1760	131	5	396	396	NUM
aiua-1760	131	6	.	.	PUNCT
aiua-1760	132	1	17	17	NUM
aiua-1760	132	2	.	.	PUNCT
aiua-1760	132	3	singer	singer	NOUN
aiua-1760	132	4	ea	ea	PROPN
aiua-1760	132	5	,	,	PUNCT
aiua-1760	132	6	palapattu	palapattu	ADJ
aiua-1760	132	7	gs	gs	PROPN
aiua-1760	132	8	,	,	PUNCT
aiua-1760	132	9	van	van	PROPN
aiua-1760	132	10	wijngaarden	wijngaarden	PROPN
aiua-1760	132	11	e.	e.	PROPN
aiua-1760	132	12	psa	psa	PROPN
aiua-1760	132	13	levels	level	NOUN
aiua-1760	132	14	in	in	ADP
aiua-1760	132	15	relation	relation	NOUN
aiua-1760	132	16	to	to	ADP
aiua-1760	132	17	consumption	consumption	NOUN
aiua-1760	132	18	of	of	ADP
aiua-1760	132	19	nonsteroidal	nonsteroidal	NOUN
aiua-1760	132	20	anti	anti	ADJ
aiua-1760	132	21	-	-	ADJ
aiua-1760	132	22	inflammatory	inflammatory	ADJ
aiua-1760	132	23	drugs	drug	NOUN
aiua-1760	132	24	and	and	CCONJ
aiua-1760	132	25	acetaminophen	acetaminophen	NOUN
aiua-1760	132	26	:	:	PUNCT
aiua-1760	132	27	results	result	NOUN
aiua-1760	132	28	from	from	ADP
aiua-1760	132	29	the	the	DET
aiua-1760	132	30	2001	2001	NUM
aiua-1760	132	31	-	-	SYM
aiua-1760	132	32	2002	2002	NUM
aiua-1760	132	33	national	national	ADJ
aiua-1760	132	34	health	health	NOUN
aiua-1760	132	35	and	and	CCONJ
aiua-1760	132	36	nutrition	nutrition	NOUN
aiua-1760	132	37	examination	examination	NOUN
aiua-1760	132	38	survey	survey	NOUN
aiua-1760	132	39	.	.	PUNCT
aiua-1760	133	1	cancer	cancer	NOUN
aiua-1760	133	2	.	.	PUNCT
aiua-1760	134	1	2008	2008	NUM
aiua-1760	134	2	;	;	PUNCT
aiua-1760	134	3	113:2053	113:2053	NUM
aiua-1760	134	4	-	-	SYM
aiua-1760	134	5	7	7	NUM
aiua-1760	134	6	.	.	NOUN
aiua-1760	134	7	18	18	NUM
aiua-1760	134	8	.	.	PUNCT
aiua-1760	135	1	mahmud	mahmud	PROPN
aiua-1760	135	2	s	s	PART
aiua-1760	135	3	,	,	PUNCT
aiua-1760	135	4	franco	franco	PROPN
aiua-1760	135	5	e	e	PROPN
aiua-1760	135	6	,	,	PUNCT
aiua-1760	135	7	aprikian	aprikian	ADJ
aiua-1760	135	8	a.	a.	NOUN
aiua-1760	135	9	prostate	prostate	NOUN
aiua-1760	135	10	cancer	cancer	NOUN
aiua-1760	135	11	and	and	CCONJ
aiua-1760	135	12	use	use	NOUN
aiua-1760	135	13	of	of	ADP
aiua-1760	135	14	nonsteroidal	nonsteroidal	NOUN
aiua-1760	135	15	anti	anti	ADJ
aiua-1760	135	16	-	-	ADJ
aiua-1760	135	17	inflammatory	inflammatory	ADJ
aiua-1760	135	18	drugs	drug	NOUN
aiua-1760	135	19	:	:	PUNCT
aiua-1760	135	20	systematic	systematic	ADJ
aiua-1760	135	21	review	review	NOUN
aiua-1760	135	22	and	and	CCONJ
aiua-1760	135	23	metaanalysis	metaanalysis	NOUN
aiua-1760	135	24	.	.	PUNCT
aiua-1760	136	1	br	br	PROPN
aiua-1760	136	2	j	j	PROPN
aiua-1760	136	3	cancer	cancer	NOUN
aiua-1760	136	4	.	.	PUNCT
aiua-1760	137	1	2004	2004	NUM
aiua-1760	137	2	;	;	PUNCT
aiua-1760	137	3	90:93	90:93	NUM
aiua-1760	137	4	-	-	SYM
aiua-1760	137	5	99	99	NUM
aiua-1760	137	6	.	.	NOUN
aiua-1760	138	1	19	19	NUM
aiua-1760	138	2	.	.	X
aiua-1760	138	3	harris	harris	PROPN
aiua-1760	138	4	re	re	PROPN
aiua-1760	138	5	,	,	PUNCT
aiua-1760	138	6	beebe	beebe	NOUN
aiua-1760	138	7	-	-	PUNCT
aiua-1760	138	8	donk	donk	PROPN
aiua-1760	138	9	j	j	PROPN
aiua-1760	138	10	,	,	PUNCT
aiua-1760	138	11	doss	doss	PROPN
aiua-1760	138	12	h	h	PROPN
aiua-1760	138	13	,	,	PUNCT
aiua-1760	138	14	burr	burr	PROPN
aiua-1760	138	15	doss	doss	PROPN
aiua-1760	138	16	d.	d.	PROPN
aiua-1760	138	17	aspirin	aspirin	PROPN
aiua-1760	138	18	,	,	PUNCT
aiua-1760	138	19	ibuprofen	ibuprofen	NOUN
aiua-1760	138	20	,	,	PUNCT
aiua-1760	138	21	and	and	CCONJ
aiua-1760	138	22	other	other	ADJ
aiua-1760	138	23	non	non	ADJ
aiua-1760	138	24	-	-	ADJ
aiua-1760	138	25	steroidal	steroidal	ADJ
aiua-1760	138	26	anti	anti	ADJ
aiua-1760	138	27	-	-	ADJ
aiua-1760	138	28	inflammatory	inflammatory	ADJ
aiua-1760	138	29	drugs	drug	NOUN
aiua-1760	138	30	in	in	ADP
aiua-1760	138	31	cancer	cancer	NOUN
aiua-1760	138	32	prevention	prevention	NOUN
aiua-1760	138	33	:	:	PUNCT
aiua-1760	138	34	a	a	DET
aiua-1760	138	35	critical	critical	ADJ
aiua-1760	138	36	review	review	NOUN
aiua-1760	138	37	of	of	ADP
aiua-1760	138	38	nonselective	nonselective	ADJ
aiua-1760	138	39	cox-2	cox-2	ADJ
aiua-1760	138	40	blockade	blockade	NOUN
aiua-1760	138	41	.	.	PUNCT
aiua-1760	139	1	oncol	oncol	PROPN
aiua-1760	139	2	rep	rep	PROPN
aiua-1760	139	3	.	.	PROPN
aiua-1760	139	4	2005	2005	NUM
aiua-1760	139	5	;	;	PUNCT
aiua-1760	139	6	13:559	13:559	NUM
aiua-1760	139	7	-	-	SYM
aiua-1760	139	8	583	583	NUM
aiua-1760	139	9	.	.	PUNCT
aiua-1760	139	10	20	20	NUM
aiua-1760	139	11	.	.	PUNCT
aiua-1760	140	1	jacobs	jacobs	PROPN
aiua-1760	140	2	ej	ej	PROPN
aiua-1760	140	3	,	,	PUNCT
aiua-1760	140	4	thun	thun	PROPN
aiua-1760	140	5	mj	mj	PROPN
aiua-1760	140	6	,	,	PUNCT
aiua-1760	140	7	bain	bain	PROPN
aiua-1760	140	8	eb	eb	PROPN
aiua-1760	140	9	,	,	PUNCT
aiua-1760	140	10	et	et	PROPN
aiua-1760	140	11	al	al	PROPN
aiua-1760	140	12	.	.	PUNCT
aiua-1760	141	1	a	a	DET
aiua-1760	141	2	large	large	ADJ
aiua-1760	141	3	cohort	cohort	NOUN
aiua-1760	141	4	study	study	NOUN
aiua-1760	141	5	of	of	ADP
aiua-1760	141	6	longterm	longterm	PROPN
aiua-1760	141	7	daily	daily	ADJ
aiua-1760	141	8	use	use	NOUN
aiua-1760	141	9	of	of	ADP
aiua-1760	141	10	adult	adult	NOUN
aiua-1760	141	11	-	-	PUNCT
aiua-1760	141	12	strength	strength	NOUN
aiua-1760	141	13	aspirin	aspirin	NOUN
aiua-1760	141	14	and	and	CCONJ
aiua-1760	141	15	cancer	cancer	NOUN
aiua-1760	141	16	incidence	incidence	NOUN
aiua-1760	141	17	.	.	PUNCT
aiua-1760	142	1	j	j	PROPN
aiua-1760	142	2	natl	natl	PROPN
aiua-1760	142	3	cancer	cancer	PROPN
aiua-1760	142	4	inst	inst	PROPN
aiua-1760	142	5	.	.	PUNCT
aiua-1760	142	6	2007	2007	NUM
aiua-1760	142	7	;	;	PUNCT
aiua-1760	142	8	99:608	99:608	NUM
aiua-1760	142	9	-	-	SYM
aiua-1760	142	10	615	615	NUM
aiua-1760	142	11	.	.	PUNCT
aiua-1760	143	1	21	21	NUM
aiua-1760	143	2	.	.	PUNCT
aiua-1760	143	3	engelhardt	engelhardt	PROPN
aiua-1760	143	4	pf	pf	PROPN
aiua-1760	143	5	,	,	PUNCT
aiua-1760	143	6	rjedl	rjedl	VERB
aiua-1760	143	7	cr	cr	PROPN
aiua-1760	143	8	.	.	PUNCT
aiua-1760	144	1	effects	effect	NOUN
aiua-1760	144	2	of	of	ADP
aiua-1760	144	3	one	one	NUM
aiua-1760	144	4	-	-	PUNCT
aiua-1760	144	5	year	year	NOUN
aiua-1760	144	6	treatment	treatment	NOUN
aiua-1760	144	7	with	with	ADP
aiua-1760	144	8	isoflavone	isoflavone	NOUN
aiua-1760	144	9	extract	extract	NOUN
aiua-1760	144	10	from	from	ADP
aiua-1760	144	11	red	red	ADJ
aiua-1760	144	12	clover	clover	PROPN
aiua-1760	144	13	on	on	ADP
aiua-1760	144	14	prostate	prostate	NOUN
aiua-1760	144	15	,	,	PUNCT
aiua-1760	144	16	liver	liver	NOUN
aiua-1760	144	17	function	function	NOUN
aiua-1760	144	18	,	,	PUNCT
aiua-1760	144	19	sexual	sexual	ADJ
aiua-1760	144	20	function	function	NOUN
aiua-1760	144	21	,	,	PUNCT
aiua-1760	144	22	and	and	CCONJ
aiua-1760	144	23	quality	quality	NOUN
aiua-1760	144	24	of	of	ADP
aiua-1760	144	25	life	life	NOUN
aiua-1760	144	26	in	in	ADP
aiua-1760	144	27	men	man	NOUN
aiua-1760	144	28	with	with	ADP
aiua-1760	144	29	elevated	elevated	ADJ
aiua-1760	144	30	psa	psa	NOUN
aiua-1760	144	31	levels	level	NOUN
aiua-1760	144	32	and	and	CCONJ
aiua-1760	144	33	negative	negative	ADJ
aiua-1760	144	34	prostate	prostate	NOUN
aiua-1760	144	35	biopsy	biopsy	NOUN
aiua-1760	144	36	findings	finding	NOUN
aiua-1760	144	37	.	.	PUNCT
aiua-1760	145	1	urology	urology	NOUN
aiua-1760	145	2	.	.	PUNCT
aiua-1760	145	3	2008	2008	NUM
aiua-1760	145	4	;	;	PUNCT
aiua-1760	145	5	71:185	71:185	X
aiua-1760	145	6	-	-	SYM
aiua-1760	145	7	90	90	NUM
aiua-1760	145	8	.	.	PUNCT
aiua-1760	146	1	22	22	NUM
aiua-1760	146	2	.	.	PUNCT
aiua-1760	147	1	burnett	burnett	PROPN
aiua-1760	147	2	bp	bp	PROPN
aiua-1760	147	3	,	,	PUNCT
aiua-1760	147	4	jia	jia	PROPN
aiua-1760	147	5	q	q	PROPN
aiua-1760	147	6	,	,	PUNCT
aiua-1760	147	7	zhao	zhao	PROPN
aiua-1760	147	8	y	y	PROPN
aiua-1760	147	9	,	,	PUNCT
aiua-1760	147	10	levy	levy	PROPN
aiua-1760	147	11	rm	rm	PROPN
aiua-1760	147	12	.	.	PUNCT
aiua-1760	148	1	a	a	DET
aiua-1760	148	2	medical	medical	ADJ
aiua-1760	148	3	extract	extract	NOUN
aiua-1760	148	4	of	of	ADP
aiua-1760	148	5	scutellaria	scutellaria	NOUN
aiua-1760	148	6	baicalensis	baicalensis	NOUN
aiua-1760	148	7	and	and	CCONJ
aiua-1760	148	8	acacia	acacia	NOUN
aiua-1760	148	9	catechu	catechu	NOUN
aiua-1760	148	10	acts	act	VERB
aiua-1760	148	11	as	as	ADP
aiua-1760	148	12	dual	dual	ADJ
aiua-1760	148	13	inhibitor	inhibitor	NOUN
aiua-1760	148	14	of	of	ADP
aiua-1760	148	15	ciclooxygenase	ciclooxygenase	PROPN
aiua-1760	148	16	to	to	PART
aiua-1760	148	17	reduce	reduce	VERB
aiua-1760	148	18	inflammation	inflammation	NOUN
aiua-1760	148	19	.	.	PUNCT
aiua-1760	149	1	journal	journal	PROPN
aiua-1760	149	2	of	of	ADP
aiua-1760	149	3	medical	medical	ADJ
aiua-1760	149	4	food	food	NOUN
aiua-1760	149	5	.	.	PUNCT
aiua-1760	150	1	2007	2007	NUM
aiua-1760	150	2	;	;	PUNCT
aiua-1760	150	3	442	442	NUM
aiua-1760	150	4	-	-	SYM
aiua-1760	150	5	451	451	NUM
aiua-1760	150	6	.	.	PUNCT
aiua-1760	151	1	23	23	NUM
aiua-1760	151	2	.	.	PUNCT
aiua-1760	152	1	lixuan	lixuan	PROPN
aiua-1760	152	2	z	z	PROPN
aiua-1760	152	3	,	,	PUNCT
aiua-1760	152	4	jingcheng	jingcheng	PROPN
aiua-1760	152	5	d	d	PROPN
aiua-1760	152	6	,	,	PUNCT
aiua-1760	152	7	wengin	wengin	PROPN
aiua-1760	152	8	y	y	PROPN
aiua-1760	152	9	,	,	PUNCT
aiua-1760	153	1	et	et	PROPN
aiua-1760	153	2	al	al	PROPN
aiua-1760	153	3	.	.	PROPN
aiua-1760	153	4	baicalin	baicalin	PROPN
aiua-1760	153	5	attenuates	attenuate	VERB
aiua-1760	153	6	inflammation	inflammation	NOUN
aiua-1760	153	7	by	by	ADP
aiua-1760	153	8	inhibiting	inhibit	VERB
aiua-1760	153	9	nf	nf	ADJ
aiua-1760	153	10	-	-	PUNCT
aiua-1760	153	11	kappab	kappab	NOUN
aiua-1760	153	12	activation	activation	NOUN
aiua-1760	153	13	in	in	ADP
aiua-1760	153	14	cigarette	cigarette	NOUN
aiua-1760	153	15	smoke	smoke	NOUN
aiua-1760	153	16	induced	induce	VERB
aiua-1760	153	17	inflammatory	inflammatory	ADJ
aiua-1760	153	18	models	model	NOUN
aiua-1760	153	19	.	.	PUNCT
aiua-1760	154	1	pulm	pulm	NOUN
aiua-1760	154	2	pharmacol	pharmacol	VERB
aiua-1760	154	3	ther	ther	ADV
aiua-1760	154	4	.	.	PUNCT
aiua-1760	155	1	2010	2010	NUM
aiua-1760	155	2	;	;	PUNCT
aiua-1760	155	3	23:411	23:411	NUM
aiua-1760	155	4	-	-	SYM
aiua-1760	155	5	19	19	NUM
aiua-1760	155	6	.	.	NOUN
aiua-1760	155	7	24	24	NUM
aiua-1760	155	8	.	.	PUNCT
aiua-1760	156	1	li	li	PROPN
aiua-1760	156	2	c	c	PROPN
aiua-1760	156	3	,	,	PUNCT
aiua-1760	156	4	lin	lin	PROPN
aiua-1760	156	5	g	g	PROPN
aiua-1760	156	6	,	,	PUNCT
aiua-1760	156	7	zuo	zuo	PROPN
aiua-1760	156	8	z.	z.	PROPN
aiua-1760	156	9	pharmacological	pharmacological	NOUN
aiua-1760	156	10	effects	effect	NOUN
aiua-1760	156	11	and	and	CCONJ
aiua-1760	156	12	pharmacokinetics	pharmacokinetic	NOUN
aiua-1760	156	13	properties	property	NOUN
aiua-1760	156	14	of	of	ADP
aiua-1760	156	15	radix	radix	PROPN
aiua-1760	156	16	scutellariae	scutellariae	PROPN
aiua-1760	156	17	and	and	CCONJ
aiua-1760	156	18	its	its	PRON
aiua-1760	156	19	bioactive	bioactive	ADJ
aiua-1760	156	20	flavones	flavone	NOUN
aiua-1760	156	21	.	.	PUNCT
aiua-1760	157	1	biopharm	biopharm	NOUN
aiua-1760	157	2	drug	drug	PROPN
aiua-1760	157	3	dispos	dispos	PROPN
aiua-1760	157	4	.	.	PUNCT
aiua-1760	158	1	2011	2011	NUM
aiua-1760	158	2	;	;	PUNCT
aiua-1760	158	3	32:427	32:427	NUM
aiua-1760	158	4	-	-	SYM
aiua-1760	158	5	45	45	NUM
aiua-1760	158	6	.	.	NOUN
aiua-1760	158	7	25	25	NUM
aiua-1760	158	8	.	.	PUNCT
aiua-1760	159	1	marks	marks	PROPN
aiua-1760	159	2	ls	ls	PROPN
aiua-1760	159	3	,	,	PUNCT
aiua-1760	159	4	dipaola	dipaola	NOUN
aiua-1760	159	5	rs	rs	PROPN
aiua-1760	159	6	,	,	PUNCT
aiua-1760	159	7	nelson	nelson	PROPN
aiua-1760	159	8	p	p	PROPN
aiua-1760	159	9	,	,	PUNCT
aiua-1760	159	10	et	et	PROPN
aiua-1760	159	11	al	al	PROPN
aiua-1760	159	12	.	.	PROPN
aiua-1760	160	1	herbal	herbal	ADJ
aiua-1760	160	2	formulation	formulation	NOUN
aiua-1760	160	3	for	for	ADP
aiua-1760	160	4	prostate	prostate	NOUN
aiua-1760	160	5	cancer	cancer	NOUN
aiua-1760	160	6	.	.	PUNCT
aiua-1760	161	1	urology	urology	NOUN
aiua-1760	161	2	.	.	PUNCT
aiua-1760	162	1	2002	2002	NUM
aiua-1760	162	2	;	;	PUNCT
aiua-1760	162	3	60:369	60:369	NUM
aiua-1760	162	4	-	-	SYM
aiua-1760	162	5	75	75	NUM
aiua-1760	162	6	.	.	PUNCT
aiua-1760	163	1	correspondence	correspondence	NOUN
aiua-1760	163	2	giuseppe	giuseppe	PROPN
aiua-1760	163	3	candiano	candiano	PROPN
aiua-1760	163	4	,	,	PUNCT
aiua-1760	163	5	md	md	PROPN
aiua-1760	163	6	pietro	pietro	PROPN
aiua-1760	163	7	pepe	pepe	PROPN
aiua-1760	163	8	,	,	PUNCT
aiua-1760	163	9	md	md	PROPN
aiua-1760	163	10	(	(	PUNCT
aiua-1760	163	11	corresponding	correspond	VERB
aiua-1760	163	12	author	author	NOUN
aiua-1760	163	13	)	)	PUNCT
aiua-1760	163	14	piepepe@hotmail.com	piepepe@hotmail.com	X
aiua-1760	164	1	francesco	francesco	PROPN
aiua-1760	164	2	pietropaolo	pietropaolo	PROPN
aiua-1760	164	3	,	,	PUNCT
aiua-1760	164	4	md	md	PROPN
aiua-1760	164	5	francesco	francesco	PROPN
aiua-1760	164	6	aragona	aragona	PROPN
aiua-1760	164	7	,	,	PUNCT
aiua-1760	164	8	md	md	PROPN
aiua-1760	164	9	urology	urology	NOUN
aiua-1760	164	10	unit	unit	NOUN
aiua-1760	164	11	cannizzaro	cannizzaro	NOUN
aiua-1760	164	12	hospital	hospital	NOUN
aiua-1760	164	13	,	,	PUNCT
aiua-1760	164	14	via	via	ADP
aiua-1760	164	15	messina	messina	PROPN
aiua-1760	164	16	829	829	NUM
aiua-1760	164	17	catania	catania	PROPN
aiua-1760	164	18	,	,	PUNCT
aiua-1760	164	19	italy	italy	PROPN
aiua-1760	164	20	candiano_stesura	candiano_stesura	PROPN
aiua-1760	164	21	seveso	seveso	VERB
aiua-1760	164	22	24/06/13	24/06/13	PROPN
aiua-1760	164	23	10:59	10:59	NUM
aiua-1760	164	24	pagina	pagina	NOUN
aiua-1760	164	25	68	68	NUM